Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one (532 views)
Med Res Rev (ISSN: 1098-1128electronic, 0198-6325linking), 2018 Sep; 38(6): 1799-1836.
Export to BibTeX Export to EndNote
Paper type: Journal Article, Review,
Impact factor: 8.29, 5-year impact factor: 0
Url: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045199299&doi=10.1002%2fmed.21497&partnerID=40&md5=72453483d0ff3f153254038e15e7431d
Keywords: Antibodies, Carbonic Anhydrase Ix, Diagnostic Tools, Drugs, Hypoxic Tumors, Small Molecule Inhibitors, Antimetastatic Agent, Antineoplastic Agent, Carbonate Dehydratase Ix, Carboxylic Acid, Carboxylic Acid Derivative, Coumarin Derivative, Enzyme Inhibitor, Monoclonal Antibody, Nonsteroid Antiinflammatory Agent, Phenol, Phenol Derivative, Sulfonamide, Arthritis, Brain Ischemia, Cancer Stem Cell, Catalysis, Cell Invasion, Cell Migration, Cell Survival, Enzyme Inhibition, Enzyme Structure, Human, Metastasis, Nonhuman, Primary Tumor, Protein Expression, Review, Solid Malignant Neoplasm,
Affiliations:
*** IBB - CNR ***
Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Universita degli Studi di Firenze, Florence, Italy., Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy.,
References:
Alterio, V., Di Fiore, A., D'Ambrosio, K., Supuran, C.T., De Simone, G., Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms (2012) Chem Rev, 112, pp. 4421-446
Zavada, J., Zavadova, Z., An unusual transmissible agent–MaTu (1991) Arch Virol, 118, pp. 189-197
Pastorekova, S., Zavadova, Z., Kostal, M., Babusikova, O., Zavada, J., A novel quasi-viral agent, MaTu, is a two-component system (1992) Virology, 187, pp. 620-626
Pastorek, J., Pastorekova, S., Callebaut, I., Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment (1994) Oncogene, 9, pp. 2877-2888
Opavsky, R., Pastorekova, S., Zelnik, V., Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships (1996) Genomics, 33, pp. 480-487
Monti, S.M., Supuran, C.T., De Simone, G., Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013) (2013) Expert Opin Ther Pat, 23, pp. 737-749
Supuran, C.T., Di Fiore, A., Alterio, V., Monti, S.M., De Simone, G., Recent advances in structural studies of the carbonic anhydrase family: the crystal structure of human CA IX and CA XIII (2010) Curr Pharm Des, 16, pp. 3246-3254
De Simone, G., Alterio, V., Supuran, C.T., Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors (2013) Expert Opin Drug Discov, 8, pp. 793-810
Supuran, C.T., How many carbonic anhydrase inhibition mechanisms exist (2016) J Enzyme Inhib Med Chem, 31, pp. 345-360
Supuran, C.T., Structure-based drug discovery of carbonic anhydrase inhibitors (2012) J Enzyme Inhib Med Chem, 27, pp. 759-772
Pacchiano, F., Carta, F., McDonald, P.C., Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis (2011) J Med Chem, 54, pp. 1896-1902
Lou, Y., McDonald, P.C., Oloumi, A., Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors (2011) Cancer Res, 71, pp. 3364-3376
Safety Study of SLC‒0111 in Subjects With Advanced Solid Tumours, , https://clinicaltrials.gov/ct2/show/study/NCT02215850?term=SLC_0111&rank=1, Available from, (accessed July 20, 2017)
Ariser, adjuvant RENCAREX immunotherapy phase III trial to study efficacy in non metastatic RCC, , https://clinicaltrials.gov/ct2/show/NCT00087022, Available from, (accessed July 20, 2017)
Divgi, C.R., Uzzo, R.G., Gatsonis, C., Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial (2013) J Clin Oncol, 31, pp. 187-194
Buanne, P., Renzone, G., Monteleone, F., Characterization of carbonic anhydrase IX interactome reveals proteins assisting its nuclear localization in hypoxic cells (2013) J Proteome Res, 12, pp. 282-292
Bryant, D.M., Stow, J.L., Nuclear translocation of cell-surface receptors: lessons from fibroblast growth factor (2005) Traffic, 6, pp. 947-954
Wingo, T., Tu, C., Laipis, P.J., Silverman, D.N., The catalytic properties of human carbonic anhydrase IX (2001) Biochem Biophys Res Commun, 288, pp. 666-669
Hilvo, M., Baranauskiene, L., Salzano, A.M., Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes (2008) J Biol Chem, 283, pp. 27799-27809
Innocenti, A., Pastorekova, S., Pastorek, J., Scozzafava, A., De Simone, G., Supuran, C.T., The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as anintrinsic buffer optimizing CO2 hydration at acidic pH values characteristic of solid tumors (2009) Bioorg Med Chem Lett, 19, pp. 5825-5828
Funderburgh, J.L., Keratan sulfate: structure, biosynthesis, and function (2000) Glycobiology, 10, pp. 951-958
Ditte, P., Dequiedt, F., Svastova, E., Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors (2011) Cancer Res, 71, pp. 7558-7567
Dorai, T., Sawczuk, I.S., Pastorek, J., Wiernik, P.H., Dutcher, J.P., The role of carbonic anhydrase IX overexpression in kidney cancer (2005) Eur J Cancer, 41, pp. 2935-2947
Alterio, V., Hilvo, M., Di Fiore, A., Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX (2009) Proc Natl Acad Sci U S A, 106, pp. 16233-16238
Leitans, J., Kazaks, A., Balode, A., Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX (2015) J Med Chem, 58, pp. 9004-9009
Mahon, B.P., Bhatt, A., Socorro, L., The structure of carbonic anhydrase IX is adapted for low-pH catalysis (2016) Biochemistry, 55, pp. 4642-4653
Domsic, J.F., Avvaru, B.S., Kim, C.U., Entrapment of carbon dioxide in the active site of carbonic anhydrase II (2008) J Biol Chem, 283, pp. 30766-30771
Maupin, C.M., McKenna, R., Silverman, D.N., Voth, G.A., Elucidation of the proton transport mechanism in human carbonic anhydrase II (2009) J Am Chem Soc, 131, pp. 7598-7608
Tu, C.K., Silverman, D.N., Forsman, C., Jonsson, B.H., Lindskog, S., Role of histidine 64 in the catalytic mechanism of human carbonic anhydrase II studied with a site-specific mutant (1989) Biochemistry, 28, pp. 7913-7918
Silverman, D.N., McKenna, R., Solvent-mediated proton transfer in catalysis by carbonic anhydrase (2007) Acc Chem Res, 40, pp. 669-675
Roy, A., Taraphder, S., Identification of proton-transfer pathways in human carbonic anhydrase II (2007) J Phys Chem B, 111, pp. 10563-10576
Fisher, S.Z., Maupin, C.M., Budayova-Spano, M., Atomic crystal and molecular dynamics simulation structures of human carbonic anhydrase II: insights into the proton transfer mechanism (2007) Biochemistry, 46, pp. 2930-2937
Pilka, E.S., Kochan, G., Oppermann, U., Yue, W.W., Crystal structure of the secretory isozyme of mammalian carbonic anhydrases CA VI: implications for biological assembly and inhibitor development (2012) Biochem Biophys Res Commun, 419, pp. 485-489
Whittington, D.A., Waheed, A., Ulmasov, B., Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells (2001) Proc Natl Acad Sci U S A, 98, pp. 9545-9550
Di Fiore, A., Capasso, C., De Luca, V., X-ray structure of the first `extremo-alpha-carbonic anhydrase', a dimeric enzyme from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1 (2013) Acta Crystallogr D Biol Crystallogr, 69, pp. 1150-1159
Zavadova, Z., Zavada, J., Carbonic anhydrase IX (CA IX) mediates tumor cell interactions with microenvironment (2005) Oncol Rep, 13, pp. 977-982
Svastova, E., Zilka, N., Zat'ovicova, M., Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin (2003) Exp Cell Res, 290, pp. 332-345
Stiti, M., Cecchi, A., Rami, M., Carbonic anhydrase inhibitor coated gold nanoparticles selectively inhibit the tumor-associated isoform IX over the cytosolic isozymes I and II (2008) J Am Chem Soc, 130, pp. 16130-16131
Menchise, V., De Simone, G., Alterio, V., Carbonic anhydrase inhibitors: stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II (2005) J Med Chem, 48, pp. 5721-5727
Stams, T., Nair, S.K., Okuyama, T., Waheed, A., Sly, W.S., Christianson, D.W., Crystal structure of the secretory form of membrane-associated human carbonic anhydrase IV at 2.8-A resolution (1996) Proc Natl Acad Sci U S A, 93, pp. 13589-13594
Alterio, V., Pan, P., Parkkila, S., The structural comparison between membrane-associated human carbonic anhydrases provides insights into drug design of selective inhibitors (2014) Biopolymers, 101, pp. 769-778
Supuran, C.T., Acetazolamide for the treatment of idiopathic intracranial hypertension (2015) Expert Rev Neurother, 15, pp. 851-856
Pastorekova, S., Parkkila, S., Parkkila, A.K., Carbonic anhydrase IX MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts (1997) Gastroenterology, 112, pp. 398-408
Saarnio, J., Parkkila, S., Parkkila, A.K., Immunohistochemistry of carbonic anhydrase isozyme IX (MN/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity (1998) J Histochem Cytochem, 46, pp. 497-504
Kaluz, S., Kaluzova, M., Liao, S.Y., Lerman, M., Stanbridge, E.J., Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: a one transcription factor (HIF-1) show (2009) Biochim Biophys Acta, 1795, pp. 162-172
Ilardi, G., Zambrano, N., Merolla, F., Histopathological determinants of tumor resistance: a special look to the immunohistochemical expression of carbonic anhydrase IX in human cancers (2014) Curr Med Chem, 21, pp. 1569-1582
Ivanov, S., Liao, S.Y., Ivanova, A., Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer (2001) Am J Pathol, 158, pp. 905-919
Ondriskova, E., Debreova, M., Pastorekova, S., Tumor-associated carbonic anhydrases IX and XII (2015) Carbonic Anhydrases as Biocatalysts: From Theory to Medical and Industrial Applications, pp. 169-206. , Supuran CT, De Simone G, eds., Amsterdam, the Netherlands, Elsevier
Gut, M.O., Parkkila, S., Vernerova, Z., Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9 (2002) Gastroenterology, 123, pp. 1889-1903
Liao, S.Y., Aurelio, O.N., Jan, K., Zavada, J., Stanbridge, E.J., Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney (1997) Cancer Res, 57, pp. 2827-2831
Liao, S.Y., Brewer, C., Zavada, J., Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas (1994) Am J Pathol, 145, pp. 598-609
Chia, S.K., Wykoff, C.C., Watson, P.H., Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma (2001) J Clin Oncol, 19, pp. 3660-3668
Jonathan, R.A., Wijffels, K.I., Peeters, W., The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON (2006) Radiother Oncol, 79, pp. 288-297
Giatromanolaki, A., Koukourakis, M.I., Sivridis, E., Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer (2001) Cancer Res, 61, pp. 7992-7998
Vermylen, P., Roufosse, C., Burny, A., Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma (1999) Eur Respir J, 14, pp. 806-811
Turner, J.R., Odze, R.D., Crum, C.P., Resnick, M.B., MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker (1997) Hum Pathol, 28, pp. 740-744
Kowalewska, M., Radziszewski, J., Kulik, J., Detection of carbonic anhydrase 9-expressing tumor cells in the lymph nodes of vulvar carcinoma patients by RT-PCR (2005) Int J Cancer, 116, pp. 957-962
Hynninen, P., Vaskivuo, L., Saarnio, J., Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours (2006) Histopathology, 49, pp. 594-602
Kivela, A.J., Knuuttila, A., Rasanen, J., Carbonic anhydrase IX in malignant pleural mesotheliomas: a potential target for anti-cancer therapy (2013) Bioorg Med Chem, 21, pp. 1483-1488
Proescholdt, M.A., Mayer, C., Kubitza, M., Expression of hypoxia-inducible carbonic anhydrases in brain tumors (2005) Neuro Oncol, 7, pp. 465-475
Colpaert, C.G., Vermeulen, P.B., Fox, S.B., Harris, A.L., Dirix, L.Y., Van Marck, E.A., The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis (2003) Breast Cancer Res Treat, 81, pp. 137-147
Cleven, A.H., van Engeland, M., Wouters, B.G., de Bruine, A.P., Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas (2007) Cell Oncol, 29, pp. 229-240
Nakao, M., Ishii, G., Nagai, K., Prognostic significance of carbonic anhydrase IX expression by cancer-associated fibroblasts in lung adenocarcinoma (2009) Cancer, 115, pp. 2732-2743
Brockton, N., Dort, J., Lau, H., High stromal carbonic anhydrase IX expression is associated with decreased survival in P16-negative head-and-neck tumors (2011) Int J Radiat Oncol Biol Phys, 80, pp. 249-257
Brockton, N.T., Klimowicz, A.C., Bose, P., High stromal carbonic anhydrase IX expression is associated with nodal metastasis and decreased survival in patients with surgically-treated oral cavity squamous cell carcinoma (2012) Oral Oncol, 48, pp. 615-622
Fiaschi, T., Giannoni, E., Taddei, M.L., Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells (2013) Cell Cycle, 12, pp. 1791-1801
Lock, F.E., McDonald, P.C., Lou, Y., Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche (2013) Oncogene, 32, pp. 5210-5219
Kalavska, K., Cierna, Z., Chovanec, M., Prognostic value of intratumoral carbonic anhydrase IX expression in testicular germ cell tumors (2017) Oncol Lett, 13, pp. 2177-2185
Saenz-de-Santa-Maria, I., Bernardo-Castineira, C., Secades, P., Clinically relevant HIF-1alpha-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation (2017) Oncotarget, 8, pp. 13730-13746
Potter, C., Harris, A.L., Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target (2004) Cell Cycle, 3, pp. 164-167
Wykoff, C.C., Beasley, N.J., Watson, P.H., Hypoxia-inducible expression of tumor-associated carbonic anhydrases (2000) Cancer Res, 60, pp. 7075-7083
Nakazawa, M.S., Keith, B., Simon, M.C., Oxygen availability and metabolic adaptations (2016) Nat Rev Cancer, 16, pp. 663-673
Schofield, C.J., Ratcliffe, P.J., Signalling hypoxia by HIF hydroxylases (2005) Biochem Biophys Res Commun, 338, pp. 617-626
Kondo, K., The von Hippel-Lindau tumor suppressor gene (2001) Exp Cell Res, 264, pp. 117-125
Tafreshi, N.K., Lloyd, M.C., Bui, M.M., Gillies, R.J., Morse, D.L., Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases (2014) Subcell Biochem, 75, pp. 221-254
Mboge, M.Y., Mahon, B.P., McKenna, R., Frost, S.C., Carbonic Anhydrases: Role in pH Control and Cancer (2018) Metabolites, 8 (1). , https://www.ncbi.nlm.nih.gov/pubmed/29495652, pii
Swietach, P., Vaughan-Jones, R.D., Harris, A.L., Regulation of tumor pH and the role of carbonic anhydrase 9 (2007) Cancer Metastasis Rev, 26, pp. 299-310
Hulikova, A., Zat’ovicova, M., Svastova, E., Intact intracellular tail is critical for proper functioning of the tumor-associated, hypoxia-regulated carbonic anhydrase IX (2009) FEBS Lett, 583, pp. 3563-3568
Svastova, E., Witarski, W., Csaderova, L., Carbonic anhydrase IX interacts with bicarbonate transporters in lamellipodia and increases cell migration via its catalytic domain (2012) J Biol Chem, 287, pp. 3392-3402
Radvak, P., Repic, M., Svastova, E., Suppression of carbonic anhydrase IX leads to aberrant focal adhesion and decreased invasion of tumor cells (2013) Oncol Rep, 29, pp. 1147-1153
Chiche, J., Ilc, K., Laferriere, J., Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH (2009) Cancer Res, 69, pp. 358-368
Stubbs, M., McSheehy, P.M., Griffiths, J.R., Bashford, C.L., Causes and consequences of tumour acidity and implications for treatment (2000) Mol Med today, 6, pp. 15-19
Helmlinger, G., Sckell, A., Dellian, M., Forbes, N.S., Jain, R.K., Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism (2002) Clin Cancer Res, 8, pp. 1284-1291
Fukumura, D., Jain, R.K., Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize (2007) J Cell Biochem, 101, pp. 937-949
Raghunand, N., Gatenby, R.A., Gillies, R.J., Microenvironmental and cellular consequences of altered blood flow in tumours (2003) Br J Radiol, 76 (Spec No 1), pp. S11-S22
Svastova, E., Hulikova, A., Rafajova, M., Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH (2004) FEBS Lett, 577, pp. 439-445
Shin, H.J., Rho, S.B., Jung, D.C., Han, I.O., Oh, E.S., Kim, J.Y., Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion (2011) J Cell Sci, 124, pp. 1077-1087
Csaderova, L., Debreova, M., Radvak, P., The effect of carbonic anhydrase IX on focal contacts during cell spreading and migration (2013) Front Physiol, 4, p. 271
Buonanno, M., Langella, E., Zambrano, N., Disclosing the interaction of carbonic anhydrase IX with cullin-associated NEDD8-dissociated protein 1 by molecular modeling and integrated binding measurements (2017) ACS Chem Biol, 12, pp. 1460-1465
Swayampakula, M., McDonald, P.C., Vallejo, M., The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia/MMP14-mediated invasion (2017) Oncogene, 36, pp. 6244-6261
Oosterwijk, E., Ruiter, D.J., Hoedemaeker, P.J., Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney (1986) Int J Cancer, 38, pp. 489-494
Zatovicova, M., Jelenska, L., Hulikova, A., Monoclonal antibody G250 targeting CA: binding specificity, internalization and therapeutic effects in a non-renal cancer model (2014) Int J Oncol, 45, pp. 2455-2467
van Dijk, J., Zegveld, S.T., Fleuren, G.J., Warnaar, S.O., Localization of monoclonal antibody G250 and bispecific monoclonal antibody CD3/G250 in human renal-cell carcinoma xenografts: relative effects of size and affinity (1991) Int J Cancer, 48, pp. 738-743
Kranenborg, M.H., Boerman, O.C., de Weijert, M.C., Oosterwijk-Wakka, J.C., Corstens, F.H., Oosterwijk, E., The effect of antibody protein dose of anti-renal cell carcinoma monoclonal antibodies in nude mice with renal cell carcinoma xenografts (1997) Cancer, 80, pp. 2390-2397
Steffens, M.G., Oosterwijk, E., Kranenborg, M.H., In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations (1999) J Nucl Med, 40, pp. 829-836
Steffens, M.G., Kranenborg, M.H., Boerman, O.C., Tumor retention of 186Re-MAG3, 111In-DTPA and 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts (1998) Cancer Biother Radiopharm, 13, pp. 133-139
Oosterwijk, E., Bander, N.H., Divgi, C.R., Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250 (1993) J Clin Oncol, 11, pp. 738-750
Divgi, C.R., Bander, N.H., Scott, A.M., Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma (1998) Clin Cancer Res, 4, pp. 2729-2739
Belldegrun, A.S., Chamie, K., Kloepfer, P., ARISER: a randomized double blind phase III study to evaluate adjuvant cG250 treatment versus placebo in patients with high-risk ccRCC: results and implications for adjuvant clinical trials (2013) J Clin Oncol, 31, p. 4507
Chrastina, A., Zavada, J., Parkkila, S., Biodistribution and pharmacokinetics of I-125-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma (2003) Int J Cancer, 105, pp. 873-881
Klatte, T., Seligson, D.B., Rao, J.Y., Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker (2009) Cancer, 115, pp. 1448-1458
Jensen, H.K., Nordsmark, M., Donskov, F., Marcussen, N., von der Maase, H., Immunohistochemical expression of carbonic anhydrase IX assessed over time and during treatment in renal cell carcinoma (2008) BJU Int, 101, pp. 41-44
Kral, V., Mader, P., Collard, R., Stabilization of antibody structure upon association to a human carbonic anhydrase IX epitope studied by X-ray crystallography, microcalorimetry, and molecular dynamics simulations (2008) Proteins, 71, pp. 1275-1287
Zat'ovicova, M., Tarabkova, K., Svastova, E., Monoclonal antibodies generated in carbonic anhydrase IX-deficient mice recognize different domains of tumour-associated hypoxia-induced carbonic anhydrase IX (2003) J Immunol Methods, 282, pp. 117-134
Zat’ovicova, M., Jelenska, L., Hulikova, A., Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain (2010) Curr Pharm Des, 16, pp. 3255-3263
Ahlskog, J.K., Schliemann, C., Marlind, J., Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours (2009) Br J Cancer, 101, pp. 645-657
Murri-Plesko, M.T., Hulikova, A., Oosterwijk, E., Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX (2011) Eur J Pharmacol, 657, pp. 173-183
Supuran, C.T., Carbonic anhydrases: novel therapeutic applications for inhibitors and activators (2008) Nat Rev Drug Discov, 7, pp. 168-181
Neri, D., Supuran, C.T., Interfering with pH regulation in tumours as a therapeutic strategy (2011) Nat Rev Drug Discov, 10, pp. 767-777
Supuran, C.T., Advances in structure-based drug discovery of carbonic anhydrase inhibitors (2017) Expert Opin Drug Discov, 12, pp. 61-88
Vullo, D., Franchi, M., Gallori, E., Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides (2003) Bioorg Med Chem Lett, 13, pp. 1005-1009
Scozzafava, A., Menabuoni, L., Mincione, F., Briganti, F., Mincione, G., Supuran, C.T., Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring (1999) J Med Chem, 42, pp. 2641-2650
Scozzafava, A., Briganti, F., Mincione, G., Menabuoni, L., Mincione, F., Supuran, C.T., Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route (1999) J Med Chem, 42, pp. 3690-3700
Ilies, M.A., Vullo, D., Pastorek, J., Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives (2003) J Med Chem, 46, pp. 2187-2196
Franchi, M., Vullo, D., Gallori, E., Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with lipophilic sulfonamides (2003) J Enzyme Inhib Med Chem, 18, pp. 333-338
Pastorekova, S., Casini, A., Scozzafava, A., Vullo, D., Pastorek, J., Supuran, C.T., Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX (2004) Bioorg Med Chem Lett, 14, pp. 869-873
Casey, J.R., Morgan, P.E., Vullo, D., Scozzafava, A., Mastrolorenzo, A., Supuran, C.T., Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX (2004) J Med Chem, 47, pp. 2337-2347
Garaj, V., Puccetti, L., Fasolis, G., Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties (2004) Bioorg Med Chem Lett, 14, pp. 5427-5433
Di Fiore, A., De Simone, G., Menchise, V., Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II (2005) Bioorg Med Chem Lett, 15, pp. 1937-1942
Cecchi, A., Hulikova, A., Pastorek, J., Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors (2005) J Med Chem, 48, pp. 4834-4841
Alterio, V., Vitale, R.M., Monti, S.M., Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX (2006) J Am Chem Soc, 128, pp. 8329-8335
DeSimone, G., Vitale, R.M., Di Fiore, A., Carbonic anhydrase inhibitors: hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX (2006) J Med Chem, 49, pp. 5544-5551
Wilkinson, B.L., Bornaghi, L.F., Houston, T.A., Innocenti, A., Supuran, C.T., Poulsen, S.A., A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by “click-tailing” (2006) J Med Chem, 49, pp. 6539-6548
Smaine, F.Z., Winum, J.Y., Montero, J.L., Carbonic anhydrase inhibitors: selective inhibition of the extracellular, tumor-associated isoforms IX and XII over isozymes I and II with glycosyl-thioureido-sulfonamides (2007) Bioorg Med Chem Lett, 17, pp. 5096-5100
Guzel, O., Temperini, C., Innocenti, A., Scozzafava, A., Salman, A., Supuran, C.T., Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies (2008) Bioorg Med Chem Lett, 18, pp. 152-158
Rami, M., Winum, J.Y., Innocenti, A., Montero, J.L., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: copper(II) complexes of polyamino-polycarboxylamido aromatic/heterocyclic sulfonamides are very potent inhibitors of the tumor-associated isoforms IX and XII (2008) Bioorg Med Chem Lett, 18, pp. 836-841
D'Ambrosio, K., Vitale, R.M., Dogne, J.M., Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII (2008) J Med Chem, 51, pp. 3230-3237
Rami, M., Cecchi, A., Montero, J.L., Carbonic anhydrase inhibitors: design of membrane-impermeant copper(II) complexes of DTPA-, DOTA-, and TETA-tailed sulfonamides targeting the tumor-associated transmembrane isoform IX (2008) ChemMedChem, 3, pp. 1780-1788
Vomasta, D., Innocenti, A., Konig, B., Supuran, C.T., Carbonic anhydrase inhibitors: two-prong versus mono-prong inhibitors of isoforms I, II, IX, and XII exemplified by photochromic cis-1,2-alpha-dithienylethene derivatives (2009) Bioorg Med Chem Lett, 19, pp. 1283-1286
Carta, F., Maresca, A., Scozzafava, A., Vullo, D., Supuran, C.T., Carbonic anhydrase inhibitors. Diazenylbenzenesulfonamides are potent and selective inhibitors of the tumor-associated isozymes IX and XII over the cytosolic isoforms I and II (2009) Bioorg Med Chem, 17, pp. 7093-7099
Brzozowski, Z., Slawinski, J., Saczewski, F., Innocenti, A., Supuran, C.T., Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides (2010) Eur J Med Chem, 45, pp. 2396-2404
Marques, S.M., Enyedy, E.A., Supuran, C.T., Krupenko, N.I., Krupenko, S.A., Santos, M.A., Pteridine-sulfonamide conjugates as dual inhibitors of carbonic anhydrases and dihydrofolate reductase with potential antitumor activity (2010) Bioorg Med Chem, 18, pp. 5081-5089
Buller, F., Steiner, M., Frey, K., Selection of carbonic anhydrase IX inhibitors from one million DNA-encoded compounds (2011) ACS Chem Biol, 6, pp. 336-344
Rami, M., Maresca, A., Smaine, F.Z., Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII (2011) Bioorg Med Chem Lett, 21, pp. 2975-2979
Carta, F., Garaj, V., Maresca, A., Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: solution and X-ray crystallographic studies (2011) Bioorg Med Chem, 19, pp. 3105-3119
Morris, J.C., Chiche, J., Grellier, C., Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors (2011) J Med Chem, 54, pp. 6905-6918
Groves, K., Bao, B., Zhang, J., Synthesis and evaluation of near-infrared fluorescent sulfonamide derivatives for imaging of hypoxia-induced carbonic anhydrase IX expression in tumors (2012) Bioorg Med Chem Lett, 22, pp. 653-657
Can, D., Spingler, B., Schmutz, P., [(Cp-R)M(CO)3] (M = Re or 99mTc) Arylsulfonamide, arylsulfamide, and arylsulfamate conjugates for selective targeting of human carbonic anhydrase IX (2012) Angew Chem Int Ed Engl, 51, pp. 3354-3357
Gieling, R.G., Babur, M., Mamnani, L., Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts (2012) J Med Chem, 55, pp. 5591-5600
Winum, J.Y., Carta, F., Ward, C., Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines (2012) Bioorg Med Chem Lett, 22, pp. 4681-4685
D'Ambrosio, K., Smaine, F.Z., Carta, F., De Simone, G., Winum, J.Y., Supuran, C.T., Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups (2012) J Med Chem, 55, pp. 6776-6783
Guzel-Akdemir, O., Akdemir, A., Isik, S., Vullo, D., Supuran, C.T., o-Benzenedisulfonimido-sulfonamides are potent inhibitors of the tumor-associated carbonic anhydrase isoforms CA IX and CA XII (2013) Bioorg Med Chem, 21, pp. 1386-1391
Saada, M.C., Ombouma, J., Montero, J.L., Supuran, C.T., Winum, J.Y., Thiol-ene click chemistry for the synthesis of highly effective glycosyl sulfonamide carbonic anhydrase inhibitors (2013) Chem Commun (Camb), 49, pp. 5699-5701
Akdemir, A., Guzel-Akdemir, O., Scozzafava, A., Capasso, C., Supuran, C.T., Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides (2013) Bioorg Med Chem, 21, pp. 5228-5232
Rami, M., Dubois, L., Parvathaneni, N.K., Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates (2013) J Med Chem, 56, pp. 8512-8520
Sethi, K.K., Verma, S.M., Tanc, M., Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties (2014) Bioorg Med Chem, 22, pp. 1586-1595
Khloya, P., Celik, G., SitaRam, Vullo, D., Supuran, C.T., Sharma, P.K., 4-Functionalized 1,3-diarylpyrazoles bearing benzenesulfonamide moiety as selective potent inhibitors of the tumor associated carbonic anhydrase isoforms IX and XII (2014) Eur J Med Chem, 76, pp. 284-290
Krall, N., Pretto, F., Decurtins, W., Bernardes, G.J., Supuran, C.T., Neri, D., A small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors (2014) Angew Chem Int Ed Engl, 53, pp. 4231-4235
Moeker, J., Peat, T.S., Bornaghi, L.F., Vullo, D., Supuran, C.T., Poulsen, S.A., Cyclic secondary sulfonamides: unusually good inhibitors of cancer-related carbonic anhydrase enzymes (2014) J Med Chem, 57, pp. 3522-3531
Rosatelli, E., Carotti, A., Ceruso, M., Supuran, C.T., Gioiello, A., Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors (2014) Bioorg Med Chem Lett, 24, pp. 3422-3425
Pala, N., Micheletto, L., Sechi, M., Carbonic anhydrase inhibition with benzenesulfonamides and tetrafluorobenzenesulfonamides obtained via click chemistry (2014) ACS Med Chem Lett, 5, pp. 927-930
Ghorab, M.M., Ceruso, M., Alsaid, M.S., Nissan, Y.M., Arafa, R.K., Supuran, C.T., Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: synthesis, cytotoxic activity and molecular modeling (2014) Eur J Med Chem, 87, pp. 186-196
Mahon, B.P., Hendon, A.M., Driscoll, J.M., Saccharin: a lead compound for structure-based drug design of carbonic anhydrase IX inhibitors (2015) Bioorg Med Chem, 23, pp. 849-854
Dilworth, J.R., Pascu, S.I., Waghorn, P.A., Synthesis of sulfonamide conjugates of Cu(II), Ga(III), In(III), Re(V) and Zn(II) complexes: carbonic anhydrase inhibition studies and cellular imaging investigations (2015) Dalton Trans, 44, pp. 4859-4873
Ceruso, M., Antel, S., Scozzafava, A., Supuran, C.T., Synthesis and inhibition potency of novel ureido benzenesulfonamides incorporating GABA as tumor-associated carbonic anhydrase IX and XII inhibitors (2016) J Enzyme Inhib Med Chem, 31, pp. 205-211
Carta, F., Osman, S.M., Vullo, D., Poly(amidoamine) dendrimers with carbonic anhydrase inhibitory activity and antiglaucoma action (2015) J Med Chem, 58, pp. 4039-4045
Carta, F., Ferraroni, M., Scozzafava, A., Supuran, C.T., Fluorescent sulfonamide carbonic anhydrase inhibitors incorporating 1,2,3-triazole moieties: kinetic and X-ray crystallographic studies (2016) Bioorg Med Chem, 24, pp. 104-112
Cornelio, B., Laronze-Cochard, M., Ceruso, M., 4-Arylbenzenesulfonamides as human carbonic anhydrase inhibitors (hCAIs): synthesis by Pd nanocatalyst-mediated Suzuki-Miyaura reaction, enzyme inhibition, and X-ray crystallographic studies (2016) J Med Chem, 59, pp. 721-732
Lomelino, C.L., Mahon, B.P., McKenna, R., Carta, F., Supuran, C.T., Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111 (2016) Bioorg Med Chem, 24, pp. 976-981
Chandak, N., Ceruso, M., Supuran, C.T., Sharma, P.K., Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII (2016) Bioorg Med Chem, 24, pp. 2882-2886
Akocak, S., Alam, M.R., Shabana, A.M., PEGylated bis-sulfonamide carbonic anhydrase inhibitors can efficiently control the growth of several carbonic anhydrase IX-expressing carcinomas (2016) J Med Chem, 59, pp. 5077-5088
Mujumdar, P., Teruya, K., Tonissen, K.F., An unusual natural product primary sulfonamide: synthesis, carbonic anhydrase inhibition, and protein X-ray structures of psammaplin C (2016) J Med Chem, 59, pp. 5462-5470
Coviello, V., Marchi, B., Sartini, S., 1,2-Benzisothiazole derivatives bearing 4-, 5-, or 6-alkyl/arylcarboxamide moieties inhibit carbonic anhydrase isoform IX (CAIX) and cell proliferation under hypoxic conditions (2016) J Med Chem, 59, pp. 6547-6552
Nocentini, A., Vullo, D., Bartolucci, G., Supuran, C.T., N-Nitrosulfonamides: a new chemotype for carbonic anhydrase inhibition (2016) Bioorg Med Chem, 24, pp. 3612-3617
Gul, H.I., Mete, E., Eren, S.E., Sakagami, H., Yamali, C., Supuran, C.T., Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4,5-dihydro-pyrazol-1-yl]benzenesulfonamides (2017) J Enzyme Inhib Med Chem, 32, pp. 169-175
Melis, C., Meleddu, R., Angeli, A., Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors (2017) J Enzyme Inhib Med Chem, 32, pp. 68-73
van Kuijk, S.J., Parvathaneni, N.K., Niemans, R., New approach of delivering cytotoxic drugs towards CAIX expressing cells: a concept of dual-target drugs (2017) Eur J Med Chem, 127, pp. 691-702
Nocentini, A., Ferraroni, M., Carta, F., Benzenesulfonamides incorporating flexible triazole moieties are highly effective carbonic anhydrase inhibitors: synthesis and kinetic, crystallographic, computational, and intraocular pressure lowering investigations (2016) J Med Chem, 59, pp. 10692-10704
Ivanova, J., Balode, A., Zalubovskis, R., 5-Substituted-benzylsulfanyl-thiophene-2-sulfonamides with effective carbonic anhydrase inhibitory activity: solution and crystallographic investigations (2017) Bioorg Med Chem, 25, pp. 857-863
Carta, F., Birkmann, A., Pfaff, T., Lead development of thiazolylsulfonamides with carbonic anhydrase inhibitory action (2017) J Med Chem, 60, pp. 3154-3164
Bragagni, M., Carta, F., Osman, S.M., AlOthman, Z., Supuran, C.T., Synthesis of an acridine orange sulfonamide derivative with potent carbonic anhydrase IX inhibitory action (2017) J Enzyme Inhib Med Chem, 32, pp. 701-706
Guzel, O., Maresca, A., Scozzafava, A., Salman, A., Balaban, A.T., Supuran, C.T., Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII (2009) Bioorg Med Chem Lett, 19, pp. 2931-2934
Bozdag, M., Ferraroni, M., Nuti, E., Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies (2014) Bioorg Med Chem, 22, pp. 334-340
Leitans, J., Sprudza, A., Tanc, M., 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies (2013) Bioorg Med Chem, 21, pp. 5130-5138
Carta, F., Vullo, D., Osman, S.M., AlOthman, Z., Supuran, C.T., Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs (2017) Bioorg Med Chem, 25, pp. 2569-2576
Angeli, A., Carta, F., Bartolucci, G., Supuran, C.T., Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors (2017) Bioorg Med Chem, 25, pp. 3567-3573
Abdoli, M., Angeli, A., Bozdag, M., Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides (2017) J Enzyme Inhib Med Chem, 32, pp. 1071-1078
Angeli, A., Abdel-Aziz, A.A., Nocentini, A., El-Azab, A.S., Gratteri, P., Supuran, C.T., Synthesis and carbonic anhydrase inhibition of polycyclic imides incorporating N-benzenesulfonamide moieties (2017) Bioorg Med Chem, 25, pp. 5373-5379
Kumar, R., Sharma, V., Bua, S., Supuran, C.T., Sharma, P.K., Synthesis and biological evaluation of benzenesulphonamide-bearing 1,4,5-trisubstituted-1,2,3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity (2017) J Enzyme Inhib Med Chem, 32, pp. 1187-1194
Angeli, A., Tanini, D., Peat, T.S., Discovery of new selenoureido analogues of 4-(4-fluorophenylureido)benzenesulfonamide as carbonic anhydrase inhibitors (2017) ACS Med Chem Lett, 8, pp. 963-968
Ramya, P.V.S., Angapelly, S., Angeli, A., Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors (2017) J Enzyme Inhib Med Chem, 32, pp. 1274-1281
Winum, J.Y., Pastorekova, S., Jakubickova, L., Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates (2005) Bioorg Med Chem Lett, 15, pp. 579-584
Colinas, P.A., Bravo, R.D., Vullo, D., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I and II, and extracellular isoforms IV, IX, and XII with sulfamides incorporating sugar moieties (2007) Bioorg Med Chem Lett, 17, pp. 5086-5090
Ombouma, J., Vullo, D., Dumy, P., Supuran, C.T., Winum, J.Y., Carbonic anhydrase glycoinhibitors belonging to the aminoxysulfonamide series (2015) ACS Med Chem Lett, 6, pp. 819-821
Vitale, R.M., Alterio, V., Innocenti, A., Carbonic anhydrase inhibitors. Comparison of aliphatic sulfamate/bis-sulfamate adducts with isozymes II and IX as a platform for designing tight-binding, more isoform-selective inhibitors (2009) J Med Chem, 52, pp. 5990-5998
Lopez, M., Paul, B., Hofmann, A., S-glycosyl primary sulfonamides: a new structural class for selective inhibition of cancer-associated carbonic anhydrases (2009) J Med Chem, 52, pp. 6421-6432
Kohler, K., Hillebrecht, A., Schulze Wischeler, J., Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste (2007) Angew Chem Int Ed Engl, 46, pp. 7697-7699
De Simone, G., Langella, E., Esposito, D., Insights into the binding mode of sulphamates and sulphamides to hCA II: crystallographic studies and binding free energy calculations (2017) J Enzyme Inhib Med Chem, 32, pp. 1002-1011
Alterio, V., Esposito, D., Monti, S.M., Supuran, C.T., De Simone, G., Crystal structure of the human carbonic anhydrase II adduct with 1-(4-sulfamoylphenyl-ethyl)-2,4,6-triphenylpyridinium perchlorate, a membrane-impermeant, isoform selective inhibitor (2018) J Enzyme Inhib Med Chem, 33, pp. 151-157
Pacchiano, F., Aggarwal, M., Avvaru, B.S., Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency (2010) Chem Commun (Camb), 46, pp. 8371-8373
Innocenti, A., Vullo, D., Scozzafava, A., Casey, J.R., Supuran, C., Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates (2005) Bioorg Med Chem Lett, 15, pp. 573-578
Langella, E., D'Ambrosio, K., D'Ascenzio, M., A combined crystallographic and theoretical study explains the capability of carboxylic acids to adopt multiple binding modes in the active site of carbonic anhydrases (2016) Chemistry, 22, pp. 97-100
D'Ambrosio, K., Carradori, S., Monti, S.M., Out of the active site binding pocket for carbonic anhydrase inhibitors (2015) Chem Commun (Camb), 51, pp. 302-305
Maresca, A., Akyuz, G., Osman, S.M., AlOthman, Z., Supuran, C.T., Inhibition of mammalian carbonic anhydrase isoforms I-XIV with a series of phenolic acid esters (2015) Bioorg Med Chem, 23, pp. 7181-7188
Innocenti, A., Beyza Ozturk Sarikaya, S., Gulcin, I., Supuran, C.T., Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids (2010) Bioorg Med Chem, 18, pp. 2159-2164
Martin, D.P., Cohen, S.M., Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors (2012) Chem Commun (Camb), 48, pp. 5259-5261
Maresca, A., Temperini, C., Vu, H., Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors (2009) J Am Chem Soc, 131, pp. 3057-3062
Abdel-Aziz, A.A., El-Azab, A.S., Ceruso, M., Supuran, C.T., Carbonic anhydrase inhibitory activity of sulfonamides and carboxylic acids incorporating cyclic imide scaffolds (2014) Bioorg Med Chem Lett, 24, pp. 5185-5189
El-Azab, A.S., Abdel-Aziz, A.A., Ayyad, R.R., Ceruso, M., Supuran, C.T., Inhibition of carbonic anhydrase isoforms I, II, IV, VII and XII with carboxylates and sulfonamides incorporating phthalimide/phthalic anhydride scaffolds (2016) Bioorg Med Chem, 24, pp. 20-25
Barresi, E., Salerno, S., Marini, A.M., Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII (2016) Bioorg Med Chem, 24, pp. 921-927
Cvijetic, I.N., Tanc, M., Juranic, I.O., Verbic, T.Z., Supuran, C.T., Drakulic, B.J., 5-Aryl-1H-pyrazole-3-carboxylic acids as selective inhibitors of human carbonic anhydrases IX and XII (2015) Bioorg Med Chem, 23, pp. 4649-4659
Cadoni, R., Pala, N., Lomelino, C., Exploring heteroaryl-pyrazole carboxylic acids as human carbonic anhydrase XII inhibitors (2017) ACS Med Chem Lett, 8, pp. 941-946
Boztas, M., Cetinkaya, Y., Topal, M., Synthesis and carbonic anhydrase isoenzymes I, II, IX, and XII inhibitory effects of dimethoxybromophenol derivatives incorporating cyclopropane moieties (2015) J Med Chem, 58, pp. 640-650
Carradori, S., De Monte, C., D'Ascenzio, M., Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII: a new scaffold for designing isoform-selective inhibitors (2013) Bioorg Med Chem Lett, 23, pp. 6759-6763
Durdagi, S., Senturk, M., Ekinci, D., Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site (2011) Bioorg Med Chem, 19, pp. 1381-1389
Innocenti, A., Gulcin, I., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV (2010) Bioorg Med Chem Lett, 20, pp. 5050-5053
Karioti, A., Ceruso, M., Carta, F., Bilia, A.R., Supuran, C.T., New natural product carbonic anhydrase inhibitors incorporating phenol moieties (2015) Bioorg Med Chem, 23, pp. 7219-7225
Scozzafava, A., Passaponti, M., Supuran, C.T., Gulcin, I., Carbonic anhydrase inhibitors: guaiacol and catechol derivatives effectively inhibit certain human carbonic anhydrase isoenzymes (hCA I, II, IX and XII) (2015) J Enzyme Inhib Med Chem, 30, pp. 586-591
Yamali, C., Gul, H.I., Sakagami, H., Supuran, C.T., Synthesis and bioactivities of halogen bearing phenolic chalcones and their corresponding bis Mannich bases (2016) J Enzyme Inhib Med Chem, 31, pp. 125-131
Abellan-Flos, M., Tanc, M., Supuran, C.T., Vincent, S.P., Exploring carbonic anhydrase inhibition with multimeric coumarins displayed on a fullerene scaffold (2015) Org Biomol Chem, 13, pp. 7445-7451
Bonneau, A., Maresca, A., Winum, J.Y., Supuran, C.T., Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonic anhydrase inhibitors (2013) J Enzyme Inhib Med Chem, 28, pp. 397-401
Bozdag, M., Alafeefy, A.M., Altamimi, A.M., Vullo, D., Carta, F., Supuran, C.T., Coumarins and other fused bicyclic heterocycles with selective tumor-associated carbonic anhydrase isoforms inhibitory activity (2017) Bioorg Med Chem, 25, pp. 677-683
Bua, S., Di Cesare Mannelli, L., Vullo, D., Design and synthesis of novel nonsteroidal anti-inflammatory drugs and carbonic anhydrase inhibitors hybrids (NSAIDs-CAIs) for the treatment of rheumatoid arthritis (2017) J Med Chem, 60, pp. 1159-1170
Davis, R.A., Vullo, D., Maresca, A., Supuran, C.T., Poulsen, S.A., Natural product coumarins that inhibit human carbonic anhydrases (2013) Bioorg Med Chem, 21, pp. 1539-1543
Kucukbay, F.Z., Kucukbay, H., Tanc, M., Supuran, C.T., Synthesis and carbonic anhydrase inhibitory properties of amino acid: coumarin/quinolinone conjugates incorporating glycine, alanine and phenylalanine moieties (2016) J Enzyme Inhib Med Chem, 31, pp. 1198-1202
Nocentini, A., Carta, F., Ceruso, M., Bartolucci, G., Supuran, C.T., Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII (2015) Bioorg Med Chem, 23, pp. 6955-6966
Sharma, A., Tiwari, M., Supuran, C.T., Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX (2014) J Enzyme Inhib Med Chem, 29, pp. 292-296
Touisni, N., Maresca, A., McDonald, P.C., Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors (2011) J Med Chem, 54, pp. 8271-8277
Vullo, D., Isik, S., Bozdag, M., Carta, F., Supuran, C.T., 7-Amino-3,4-dihydro-1H-quinolin-2-one, a compound similar to the substituted coumarins, inhibits alpha-carbonic anhydrases without hydrolysis of the lactam ring (2015) J Enzyme Inhib Med Chem, 30, pp. 773-777
Grandane, A., Tanc, M., Di Cesare Mannelli, L., 6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells (2015) J Med Chem, 58, pp. 3975-3983
Nocentini, A., Ceruso, M., Carta, F., Supuran, C.T., 7-Aryl-triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrase IX and XII (2016) J Enzyme Inhib Med Chem, 31, pp. 1226-1233
Pustenko, A., Stepanovs, D., Zalubovskis, R., 3H-1,2-benzoxathiepine 2,2-dioxides: a new class of isoform-selective carbonic anhydrase inhibitors (2017) J Enzyme Inhib Med Chem, 32, pp. 767-775
Tanc, M., Carta, F., Bozdag, M., Scozzafava, A., Supuran, C.T., 7-Substituted-sulfocoumarins are isoform-selective, potent carbonic anhydrase II inhibitors (2013) Bioorg Med Chem, 21, pp. 4502-4510
Tars, K., Vullo, D., Kazaks, A., Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases (2013) J Med Chem, 56, pp. 293-300
Falsini, M., Squarcialupi, L., Catarzi, D., 3-Hydroxy-1H-quinazoline-2,4-dione as a new scaffold to develop potent and selective inhibitors of the tumor-associated carbonic anhydrases IX and XII (2017) J Med Chem, 60, pp. 6428-6439
Liu, F., Martin-Mingot, A., Lecornue, F., Carbonic anhydrases inhibitory effects of new benzenesulfonamides synthesized by using superacid chemistry (2012) J Enzyme Inhib Med Chem, 27, pp. 886-891
Compain, G., Martin-Mingot, A., Maresca, A., Thibaudeau, S., Supuran, C.T., Superacid synthesis of halogen containing N-substituted-4-aminobenzene sulfonamides: new selective tumor-associated carbonic anhydrase inhibitors (2013) Bioorg Med Chem, 21, pp. 1555-1563
Metayer, B., Mingot, A., Vullo, D., Supuran, C.T., Thibaudeau, S., New superacid synthesized (fluorinated) tertiary benzenesulfonamides acting as selective hCA IX inhibitors: toward a new mode of carbonic anhydrase inhibition by sulfonamides (2013) Chem Commun (Camb), 49, pp. 6015-6017
Metayer, B., Martin-Mingot, A., Vullo, D., Supuran, C.T., Thibaudeau, S., Superacid synthesized tertiary benzenesulfonamides and benzofuzed sultams act as selective hCA IX inhibitors: toward understanding a new mode of inhibition by tertiary sulfonamides (2013) Org Biomol Chem, 11, pp. 7540-7549
Le Darz, A., Mingot, A., Bouazza, F., Fluorinated pyrrolidines and piperidines incorporating tertiary benzenesulfonamide moieties are selective carbonic anhydrase II inhibitors (2015) J Enzyme Inhib Med Chem, 30, pp. 737-745
D'Ascenzio, M., Carradori, S., De Monte, C., Secci, D., Ceruso, M., Supuran, C.T., Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII (2014) Bioorg Med Chem, 22, pp. 1821-1831
De Monte, C., Carradori, S., Secci, D., Cyclic tertiary sulfamates: selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives (2014) Eur J Med Chem, 84, pp. 240-246
Carradori, S., Mollica, A., Ceruso, M., New amide derivatives of probenecid as selective inhibitors of carbonic anhydrase IX and XII: biological evaluation and molecular modelling studies (2015) Bioorg Med Chem, 23, pp. 2975-2981
Mollica, A., Costante, R., Akdemir, A., Exploring new probenecid-based carbonic anhydrase inhibitors: synthesis, biological evaluation and docking studies (2015) Bioorg Med Chem, 23, pp. 5311-5318
D'Ascenzio, M., Guglielmi, P., Carradori, S., Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms (2017) J Enzyme Inhib Med Chem, 32, pp. 51-59
Parkkila, S., Innocenti, A., Kallio, H., Hilvo, M., Scozzafava, A., Supuran, C.T., The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian alpha-carbonic anhydrase isoforms (2009) Bioorg Med Chem Lett, 19, pp. 4102-4106
Dubois, L., Peeters, S., Lieuwes, N.G., Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation (2011) Radiother Oncol, 99, pp. 424-431
Ward, C., Meehan, J., Mullen, P., Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models (2015) Oncotarget, 6, pp. 24856-24870
Meehan, J., Ward, C., Turnbull, A., Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells (2017) Oncotarget, 8, pp. 42857-42875
Andreucci, E., Peppicelli, S., Carta, F., Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis (2017) J Mol Med (Berl), 95, pp. 1341-1353
Gieling, R.G., Parker, C.A., De Costa, L.A., Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells in vitro (2013) J Enzyme Inhib Med Chem, 28, pp. 360-369
Bryant, J.L., Gieling, R.G., Meredith, S.L., Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer (2018) Int J Cancer, 142, pp. 191-201
Logsdon, D.P., Grimard, M., Luo, M., Regulation of HIF1alpha under hypoxia by APE1/Ref-1 impacts CA9 expression: dual targeting in patient-derived 3D pancreatic cancer models (2016) Mol Cancer Ther, 15, pp. 2722-2732
Dubois, L., Douma, K., Supuran, C.T., Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors (2007) Radiother Oncol, 83, pp. 367-373
Dubois, L., Lieuwes, N.G., Maresca, A., Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model (2009) Radiother Oncol, 92, pp. 423-428
Akurathi, V., Dubois, L., Lieuwes, N.G., Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia (2010) Nucl Med Biol, 37, pp. 557-564
Peeters, S.G., Dubois, L., Lieuwes, N.G., [(18)F]VM4-037 MicroPET imaging and biodistribution of two in vivo CAIX-expressing tumor models (2015) Mol Imaging Biol, 17, pp. 615-619
Pan, J., Lau, J., Mesak, F., Synthesis and evaluation of 18F-labeled carbonic anhydrase IX inhibitors for imaging with positron emission tomography (2014) J Enzyme Inhib Med Chem, 29, pp. 249-255
Lau, J., Liu, Z., Lin, K.S., Trimeric radiofluorinated sulfonamide derivatives to achieve in vivo selectivity for carbonic anhydrase IX-targeted PET imaging (2015) J Nucl Med, 56, pp. 1434-1440
Lau, J., Zhang, Z., Jenni, S., PET imaging of carbonic anhydrase IX expression of HT-29 tumor xenograft mice with (68)Ga-labeled benzenesulfonamides (2016) Mol Pharm, 13, pp. 1137-1146
Sneddon, D., Niemans, R., Bauwens, M., Synthesis and in vivo biological evaluation of (68)Ga-labeled carbonic anhydrase IX targeting small molecules for positron emission tomography (2016) J Med Chem, 59, pp. 6431-6443
Zhang, Z., Lau, J., Zhang, C., Design, synthesis and evaluation of 18F-labeled cationic carbonic anhydrase IX inhibitors for PET imaging (2017) J Enzyme Inhib Med Chem, 32, pp. 722-730
Margheri, F., Ceruso, M., Carta, F., Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium (2016) J Enzyme Inhib Med Chem, 31, pp. 60-63
Med Res Rev (ISSN: 1098-1128electronic, 0198-6325linking), 2018 Sep; 38(6): 1799-1836.
Export to BibTeX Export to EndNote
Paper type: Journal Article, Review,
Impact factor: 8.29, 5-year impact factor: 0
Url: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045199299&doi=10.1002%2fmed.21497&partnerID=40&md5=72453483d0ff3f153254038e15e7431d
Keywords: Antibodies, Carbonic Anhydrase Ix, Diagnostic Tools, Drugs, Hypoxic Tumors, Small Molecule Inhibitors, Antimetastatic Agent, Antineoplastic Agent, Carbonate Dehydratase Ix, Carboxylic Acid, Carboxylic Acid Derivative, Coumarin Derivative, Enzyme Inhibitor, Monoclonal Antibody, Nonsteroid Antiinflammatory Agent, Phenol, Phenol Derivative, Sulfonamide, Arthritis, Brain Ischemia, Cancer Stem Cell, Catalysis, Cell Invasion, Cell Migration, Cell Survival, Enzyme Inhibition, Enzyme Structure, Human, Metastasis, Nonhuman, Primary Tumor, Protein Expression, Review, Solid Malignant Neoplasm,
Affiliations:
*** IBB - CNR ***
Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Universita degli Studi di Firenze, Florence, Italy., Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy.,
References:
Alterio, V., Di Fiore, A., D'Ambrosio, K., Supuran, C.T., De Simone, G., Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms (2012) Chem Rev, 112, pp. 4421-446
Zavada, J., Zavadova, Z., An unusual transmissible agent–MaTu (1991) Arch Virol, 118, pp. 189-197
Pastorekova, S., Zavadova, Z., Kostal, M., Babusikova, O., Zavada, J., A novel quasi-viral agent, MaTu, is a two-component system (1992) Virology, 187, pp. 620-626
Pastorek, J., Pastorekova, S., Callebaut, I., Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment (1994) Oncogene, 9, pp. 2877-2888
Opavsky, R., Pastorekova, S., Zelnik, V., Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships (1996) Genomics, 33, pp. 480-487
Monti, S.M., Supuran, C.T., De Simone, G., Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013) (2013) Expert Opin Ther Pat, 23, pp. 737-749
Supuran, C.T., Di Fiore, A., Alterio, V., Monti, S.M., De Simone, G., Recent advances in structural studies of the carbonic anhydrase family: the crystal structure of human CA IX and CA XIII (2010) Curr Pharm Des, 16, pp. 3246-3254
De Simone, G., Alterio, V., Supuran, C.T., Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors (2013) Expert Opin Drug Discov, 8, pp. 793-810
Supuran, C.T., How many carbonic anhydrase inhibition mechanisms exist (2016) J Enzyme Inhib Med Chem, 31, pp. 345-360
Supuran, C.T., Structure-based drug discovery of carbonic anhydrase inhibitors (2012) J Enzyme Inhib Med Chem, 27, pp. 759-772
Pacchiano, F., Carta, F., McDonald, P.C., Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis (2011) J Med Chem, 54, pp. 1896-1902
Lou, Y., McDonald, P.C., Oloumi, A., Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors (2011) Cancer Res, 71, pp. 3364-3376
Safety Study of SLC‒0111 in Subjects With Advanced Solid Tumours, , https://clinicaltrials.gov/ct2/show/study/NCT02215850?term=SLC_0111&rank=1, Available from, (accessed July 20, 2017)
Ariser, adjuvant RENCAREX immunotherapy phase III trial to study efficacy in non metastatic RCC, , https://clinicaltrials.gov/ct2/show/NCT00087022, Available from, (accessed July 20, 2017)
Divgi, C.R., Uzzo, R.G., Gatsonis, C., Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial (2013) J Clin Oncol, 31, pp. 187-194
Buanne, P., Renzone, G., Monteleone, F., Characterization of carbonic anhydrase IX interactome reveals proteins assisting its nuclear localization in hypoxic cells (2013) J Proteome Res, 12, pp. 282-292
Bryant, D.M., Stow, J.L., Nuclear translocation of cell-surface receptors: lessons from fibroblast growth factor (2005) Traffic, 6, pp. 947-954
Wingo, T., Tu, C., Laipis, P.J., Silverman, D.N., The catalytic properties of human carbonic anhydrase IX (2001) Biochem Biophys Res Commun, 288, pp. 666-669
Hilvo, M., Baranauskiene, L., Salzano, A.M., Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes (2008) J Biol Chem, 283, pp. 27799-27809
Innocenti, A., Pastorekova, S., Pastorek, J., Scozzafava, A., De Simone, G., Supuran, C.T., The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as anintrinsic buffer optimizing CO2 hydration at acidic pH values characteristic of solid tumors (2009) Bioorg Med Chem Lett, 19, pp. 5825-5828
Funderburgh, J.L., Keratan sulfate: structure, biosynthesis, and function (2000) Glycobiology, 10, pp. 951-958
Ditte, P., Dequiedt, F., Svastova, E., Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors (2011) Cancer Res, 71, pp. 7558-7567
Dorai, T., Sawczuk, I.S., Pastorek, J., Wiernik, P.H., Dutcher, J.P., The role of carbonic anhydrase IX overexpression in kidney cancer (2005) Eur J Cancer, 41, pp. 2935-2947
Alterio, V., Hilvo, M., Di Fiore, A., Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX (2009) Proc Natl Acad Sci U S A, 106, pp. 16233-16238
Leitans, J., Kazaks, A., Balode, A., Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX (2015) J Med Chem, 58, pp. 9004-9009
Mahon, B.P., Bhatt, A., Socorro, L., The structure of carbonic anhydrase IX is adapted for low-pH catalysis (2016) Biochemistry, 55, pp. 4642-4653
Domsic, J.F., Avvaru, B.S., Kim, C.U., Entrapment of carbon dioxide in the active site of carbonic anhydrase II (2008) J Biol Chem, 283, pp. 30766-30771
Maupin, C.M., McKenna, R., Silverman, D.N., Voth, G.A., Elucidation of the proton transport mechanism in human carbonic anhydrase II (2009) J Am Chem Soc, 131, pp. 7598-7608
Tu, C.K., Silverman, D.N., Forsman, C., Jonsson, B.H., Lindskog, S., Role of histidine 64 in the catalytic mechanism of human carbonic anhydrase II studied with a site-specific mutant (1989) Biochemistry, 28, pp. 7913-7918
Silverman, D.N., McKenna, R., Solvent-mediated proton transfer in catalysis by carbonic anhydrase (2007) Acc Chem Res, 40, pp. 669-675
Roy, A., Taraphder, S., Identification of proton-transfer pathways in human carbonic anhydrase II (2007) J Phys Chem B, 111, pp. 10563-10576
Fisher, S.Z., Maupin, C.M., Budayova-Spano, M., Atomic crystal and molecular dynamics simulation structures of human carbonic anhydrase II: insights into the proton transfer mechanism (2007) Biochemistry, 46, pp. 2930-2937
Pilka, E.S., Kochan, G., Oppermann, U., Yue, W.W., Crystal structure of the secretory isozyme of mammalian carbonic anhydrases CA VI: implications for biological assembly and inhibitor development (2012) Biochem Biophys Res Commun, 419, pp. 485-489
Whittington, D.A., Waheed, A., Ulmasov, B., Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells (2001) Proc Natl Acad Sci U S A, 98, pp. 9545-9550
Di Fiore, A., Capasso, C., De Luca, V., X-ray structure of the first `extremo-alpha-carbonic anhydrase', a dimeric enzyme from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1 (2013) Acta Crystallogr D Biol Crystallogr, 69, pp. 1150-1159
Zavadova, Z., Zavada, J., Carbonic anhydrase IX (CA IX) mediates tumor cell interactions with microenvironment (2005) Oncol Rep, 13, pp. 977-982
Svastova, E., Zilka, N., Zat'ovicova, M., Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin (2003) Exp Cell Res, 290, pp. 332-345
Stiti, M., Cecchi, A., Rami, M., Carbonic anhydrase inhibitor coated gold nanoparticles selectively inhibit the tumor-associated isoform IX over the cytosolic isozymes I and II (2008) J Am Chem Soc, 130, pp. 16130-16131
Menchise, V., De Simone, G., Alterio, V., Carbonic anhydrase inhibitors: stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II (2005) J Med Chem, 48, pp. 5721-5727
Stams, T., Nair, S.K., Okuyama, T., Waheed, A., Sly, W.S., Christianson, D.W., Crystal structure of the secretory form of membrane-associated human carbonic anhydrase IV at 2.8-A resolution (1996) Proc Natl Acad Sci U S A, 93, pp. 13589-13594
Alterio, V., Pan, P., Parkkila, S., The structural comparison between membrane-associated human carbonic anhydrases provides insights into drug design of selective inhibitors (2014) Biopolymers, 101, pp. 769-778
Supuran, C.T., Acetazolamide for the treatment of idiopathic intracranial hypertension (2015) Expert Rev Neurother, 15, pp. 851-856
Pastorekova, S., Parkkila, S., Parkkila, A.K., Carbonic anhydrase IX MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts (1997) Gastroenterology, 112, pp. 398-408
Saarnio, J., Parkkila, S., Parkkila, A.K., Immunohistochemistry of carbonic anhydrase isozyme IX (MN/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity (1998) J Histochem Cytochem, 46, pp. 497-504
Kaluz, S., Kaluzova, M., Liao, S.Y., Lerman, M., Stanbridge, E.J., Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: a one transcription factor (HIF-1) show (2009) Biochim Biophys Acta, 1795, pp. 162-172
Ilardi, G., Zambrano, N., Merolla, F., Histopathological determinants of tumor resistance: a special look to the immunohistochemical expression of carbonic anhydrase IX in human cancers (2014) Curr Med Chem, 21, pp. 1569-1582
Ivanov, S., Liao, S.Y., Ivanova, A., Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer (2001) Am J Pathol, 158, pp. 905-919
Ondriskova, E., Debreova, M., Pastorekova, S., Tumor-associated carbonic anhydrases IX and XII (2015) Carbonic Anhydrases as Biocatalysts: From Theory to Medical and Industrial Applications, pp. 169-206. , Supuran CT, De Simone G, eds., Amsterdam, the Netherlands, Elsevier
Gut, M.O., Parkkila, S., Vernerova, Z., Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9 (2002) Gastroenterology, 123, pp. 1889-1903
Liao, S.Y., Aurelio, O.N., Jan, K., Zavada, J., Stanbridge, E.J., Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney (1997) Cancer Res, 57, pp. 2827-2831
Liao, S.Y., Brewer, C., Zavada, J., Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas (1994) Am J Pathol, 145, pp. 598-609
Chia, S.K., Wykoff, C.C., Watson, P.H., Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma (2001) J Clin Oncol, 19, pp. 3660-3668
Jonathan, R.A., Wijffels, K.I., Peeters, W., The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON (2006) Radiother Oncol, 79, pp. 288-297
Giatromanolaki, A., Koukourakis, M.I., Sivridis, E., Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer (2001) Cancer Res, 61, pp. 7992-7998
Vermylen, P., Roufosse, C., Burny, A., Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma (1999) Eur Respir J, 14, pp. 806-811
Turner, J.R., Odze, R.D., Crum, C.P., Resnick, M.B., MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker (1997) Hum Pathol, 28, pp. 740-744
Kowalewska, M., Radziszewski, J., Kulik, J., Detection of carbonic anhydrase 9-expressing tumor cells in the lymph nodes of vulvar carcinoma patients by RT-PCR (2005) Int J Cancer, 116, pp. 957-962
Hynninen, P., Vaskivuo, L., Saarnio, J., Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours (2006) Histopathology, 49, pp. 594-602
Kivela, A.J., Knuuttila, A., Rasanen, J., Carbonic anhydrase IX in malignant pleural mesotheliomas: a potential target for anti-cancer therapy (2013) Bioorg Med Chem, 21, pp. 1483-1488
Proescholdt, M.A., Mayer, C., Kubitza, M., Expression of hypoxia-inducible carbonic anhydrases in brain tumors (2005) Neuro Oncol, 7, pp. 465-475
Colpaert, C.G., Vermeulen, P.B., Fox, S.B., Harris, A.L., Dirix, L.Y., Van Marck, E.A., The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis (2003) Breast Cancer Res Treat, 81, pp. 137-147
Cleven, A.H., van Engeland, M., Wouters, B.G., de Bruine, A.P., Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas (2007) Cell Oncol, 29, pp. 229-240
Nakao, M., Ishii, G., Nagai, K., Prognostic significance of carbonic anhydrase IX expression by cancer-associated fibroblasts in lung adenocarcinoma (2009) Cancer, 115, pp. 2732-2743
Brockton, N., Dort, J., Lau, H., High stromal carbonic anhydrase IX expression is associated with decreased survival in P16-negative head-and-neck tumors (2011) Int J Radiat Oncol Biol Phys, 80, pp. 249-257
Brockton, N.T., Klimowicz, A.C., Bose, P., High stromal carbonic anhydrase IX expression is associated with nodal metastasis and decreased survival in patients with surgically-treated oral cavity squamous cell carcinoma (2012) Oral Oncol, 48, pp. 615-622
Fiaschi, T., Giannoni, E., Taddei, M.L., Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells (2013) Cell Cycle, 12, pp. 1791-1801
Lock, F.E., McDonald, P.C., Lou, Y., Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche (2013) Oncogene, 32, pp. 5210-5219
Kalavska, K., Cierna, Z., Chovanec, M., Prognostic value of intratumoral carbonic anhydrase IX expression in testicular germ cell tumors (2017) Oncol Lett, 13, pp. 2177-2185
Saenz-de-Santa-Maria, I., Bernardo-Castineira, C., Secades, P., Clinically relevant HIF-1alpha-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation (2017) Oncotarget, 8, pp. 13730-13746
Potter, C., Harris, A.L., Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target (2004) Cell Cycle, 3, pp. 164-167
Wykoff, C.C., Beasley, N.J., Watson, P.H., Hypoxia-inducible expression of tumor-associated carbonic anhydrases (2000) Cancer Res, 60, pp. 7075-7083
Nakazawa, M.S., Keith, B., Simon, M.C., Oxygen availability and metabolic adaptations (2016) Nat Rev Cancer, 16, pp. 663-673
Schofield, C.J., Ratcliffe, P.J., Signalling hypoxia by HIF hydroxylases (2005) Biochem Biophys Res Commun, 338, pp. 617-626
Kondo, K., The von Hippel-Lindau tumor suppressor gene (2001) Exp Cell Res, 264, pp. 117-125
Tafreshi, N.K., Lloyd, M.C., Bui, M.M., Gillies, R.J., Morse, D.L., Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases (2014) Subcell Biochem, 75, pp. 221-254
Mboge, M.Y., Mahon, B.P., McKenna, R., Frost, S.C., Carbonic Anhydrases: Role in pH Control and Cancer (2018) Metabolites, 8 (1). , https://www.ncbi.nlm.nih.gov/pubmed/29495652, pii
Swietach, P., Vaughan-Jones, R.D., Harris, A.L., Regulation of tumor pH and the role of carbonic anhydrase 9 (2007) Cancer Metastasis Rev, 26, pp. 299-310
Hulikova, A., Zat’ovicova, M., Svastova, E., Intact intracellular tail is critical for proper functioning of the tumor-associated, hypoxia-regulated carbonic anhydrase IX (2009) FEBS Lett, 583, pp. 3563-3568
Svastova, E., Witarski, W., Csaderova, L., Carbonic anhydrase IX interacts with bicarbonate transporters in lamellipodia and increases cell migration via its catalytic domain (2012) J Biol Chem, 287, pp. 3392-3402
Radvak, P., Repic, M., Svastova, E., Suppression of carbonic anhydrase IX leads to aberrant focal adhesion and decreased invasion of tumor cells (2013) Oncol Rep, 29, pp. 1147-1153
Chiche, J., Ilc, K., Laferriere, J., Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH (2009) Cancer Res, 69, pp. 358-368
Stubbs, M., McSheehy, P.M., Griffiths, J.R., Bashford, C.L., Causes and consequences of tumour acidity and implications for treatment (2000) Mol Med today, 6, pp. 15-19
Helmlinger, G., Sckell, A., Dellian, M., Forbes, N.S., Jain, R.K., Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism (2002) Clin Cancer Res, 8, pp. 1284-1291
Fukumura, D., Jain, R.K., Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize (2007) J Cell Biochem, 101, pp. 937-949
Raghunand, N., Gatenby, R.A., Gillies, R.J., Microenvironmental and cellular consequences of altered blood flow in tumours (2003) Br J Radiol, 76 (Spec No 1), pp. S11-S22
Svastova, E., Hulikova, A., Rafajova, M., Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH (2004) FEBS Lett, 577, pp. 439-445
Shin, H.J., Rho, S.B., Jung, D.C., Han, I.O., Oh, E.S., Kim, J.Y., Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion (2011) J Cell Sci, 124, pp. 1077-1087
Csaderova, L., Debreova, M., Radvak, P., The effect of carbonic anhydrase IX on focal contacts during cell spreading and migration (2013) Front Physiol, 4, p. 271
Buonanno, M., Langella, E., Zambrano, N., Disclosing the interaction of carbonic anhydrase IX with cullin-associated NEDD8-dissociated protein 1 by molecular modeling and integrated binding measurements (2017) ACS Chem Biol, 12, pp. 1460-1465
Swayampakula, M., McDonald, P.C., Vallejo, M., The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia/MMP14-mediated invasion (2017) Oncogene, 36, pp. 6244-6261
Oosterwijk, E., Ruiter, D.J., Hoedemaeker, P.J., Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney (1986) Int J Cancer, 38, pp. 489-494
Zatovicova, M., Jelenska, L., Hulikova, A., Monoclonal antibody G250 targeting CA: binding specificity, internalization and therapeutic effects in a non-renal cancer model (2014) Int J Oncol, 45, pp. 2455-2467
van Dijk, J., Zegveld, S.T., Fleuren, G.J., Warnaar, S.O., Localization of monoclonal antibody G250 and bispecific monoclonal antibody CD3/G250 in human renal-cell carcinoma xenografts: relative effects of size and affinity (1991) Int J Cancer, 48, pp. 738-743
Kranenborg, M.H., Boerman, O.C., de Weijert, M.C., Oosterwijk-Wakka, J.C., Corstens, F.H., Oosterwijk, E., The effect of antibody protein dose of anti-renal cell carcinoma monoclonal antibodies in nude mice with renal cell carcinoma xenografts (1997) Cancer, 80, pp. 2390-2397
Steffens, M.G., Oosterwijk, E., Kranenborg, M.H., In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations (1999) J Nucl Med, 40, pp. 829-836
Steffens, M.G., Kranenborg, M.H., Boerman, O.C., Tumor retention of 186Re-MAG3, 111In-DTPA and 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts (1998) Cancer Biother Radiopharm, 13, pp. 133-139
Oosterwijk, E., Bander, N.H., Divgi, C.R., Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250 (1993) J Clin Oncol, 11, pp. 738-750
Divgi, C.R., Bander, N.H., Scott, A.M., Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma (1998) Clin Cancer Res, 4, pp. 2729-2739
Belldegrun, A.S., Chamie, K., Kloepfer, P., ARISER: a randomized double blind phase III study to evaluate adjuvant cG250 treatment versus placebo in patients with high-risk ccRCC: results and implications for adjuvant clinical trials (2013) J Clin Oncol, 31, p. 4507
Chrastina, A., Zavada, J., Parkkila, S., Biodistribution and pharmacokinetics of I-125-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma (2003) Int J Cancer, 105, pp. 873-881
Klatte, T., Seligson, D.B., Rao, J.Y., Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker (2009) Cancer, 115, pp. 1448-1458
Jensen, H.K., Nordsmark, M., Donskov, F., Marcussen, N., von der Maase, H., Immunohistochemical expression of carbonic anhydrase IX assessed over time and during treatment in renal cell carcinoma (2008) BJU Int, 101, pp. 41-44
Kral, V., Mader, P., Collard, R., Stabilization of antibody structure upon association to a human carbonic anhydrase IX epitope studied by X-ray crystallography, microcalorimetry, and molecular dynamics simulations (2008) Proteins, 71, pp. 1275-1287
Zat'ovicova, M., Tarabkova, K., Svastova, E., Monoclonal antibodies generated in carbonic anhydrase IX-deficient mice recognize different domains of tumour-associated hypoxia-induced carbonic anhydrase IX (2003) J Immunol Methods, 282, pp. 117-134
Zat’ovicova, M., Jelenska, L., Hulikova, A., Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain (2010) Curr Pharm Des, 16, pp. 3255-3263
Ahlskog, J.K., Schliemann, C., Marlind, J., Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours (2009) Br J Cancer, 101, pp. 645-657
Murri-Plesko, M.T., Hulikova, A., Oosterwijk, E., Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX (2011) Eur J Pharmacol, 657, pp. 173-183
Supuran, C.T., Carbonic anhydrases: novel therapeutic applications for inhibitors and activators (2008) Nat Rev Drug Discov, 7, pp. 168-181
Neri, D., Supuran, C.T., Interfering with pH regulation in tumours as a therapeutic strategy (2011) Nat Rev Drug Discov, 10, pp. 767-777
Supuran, C.T., Advances in structure-based drug discovery of carbonic anhydrase inhibitors (2017) Expert Opin Drug Discov, 12, pp. 61-88
Vullo, D., Franchi, M., Gallori, E., Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides (2003) Bioorg Med Chem Lett, 13, pp. 1005-1009
Scozzafava, A., Menabuoni, L., Mincione, F., Briganti, F., Mincione, G., Supuran, C.T., Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring (1999) J Med Chem, 42, pp. 2641-2650
Scozzafava, A., Briganti, F., Mincione, G., Menabuoni, L., Mincione, F., Supuran, C.T., Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route (1999) J Med Chem, 42, pp. 3690-3700
Ilies, M.A., Vullo, D., Pastorek, J., Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives (2003) J Med Chem, 46, pp. 2187-2196
Franchi, M., Vullo, D., Gallori, E., Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with lipophilic sulfonamides (2003) J Enzyme Inhib Med Chem, 18, pp. 333-338
Pastorekova, S., Casini, A., Scozzafava, A., Vullo, D., Pastorek, J., Supuran, C.T., Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX (2004) Bioorg Med Chem Lett, 14, pp. 869-873
Casey, J.R., Morgan, P.E., Vullo, D., Scozzafava, A., Mastrolorenzo, A., Supuran, C.T., Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX (2004) J Med Chem, 47, pp. 2337-2347
Garaj, V., Puccetti, L., Fasolis, G., Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties (2004) Bioorg Med Chem Lett, 14, pp. 5427-5433
Di Fiore, A., De Simone, G., Menchise, V., Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II (2005) Bioorg Med Chem Lett, 15, pp. 1937-1942
Cecchi, A., Hulikova, A., Pastorek, J., Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors (2005) J Med Chem, 48, pp. 4834-4841
Alterio, V., Vitale, R.M., Monti, S.M., Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX (2006) J Am Chem Soc, 128, pp. 8329-8335
DeSimone, G., Vitale, R.M., Di Fiore, A., Carbonic anhydrase inhibitors: hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX (2006) J Med Chem, 49, pp. 5544-5551
Wilkinson, B.L., Bornaghi, L.F., Houston, T.A., Innocenti, A., Supuran, C.T., Poulsen, S.A., A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by “click-tailing” (2006) J Med Chem, 49, pp. 6539-6548
Smaine, F.Z., Winum, J.Y., Montero, J.L., Carbonic anhydrase inhibitors: selective inhibition of the extracellular, tumor-associated isoforms IX and XII over isozymes I and II with glycosyl-thioureido-sulfonamides (2007) Bioorg Med Chem Lett, 17, pp. 5096-5100
Guzel, O., Temperini, C., Innocenti, A., Scozzafava, A., Salman, A., Supuran, C.T., Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies (2008) Bioorg Med Chem Lett, 18, pp. 152-158
Rami, M., Winum, J.Y., Innocenti, A., Montero, J.L., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: copper(II) complexes of polyamino-polycarboxylamido aromatic/heterocyclic sulfonamides are very potent inhibitors of the tumor-associated isoforms IX and XII (2008) Bioorg Med Chem Lett, 18, pp. 836-841
D'Ambrosio, K., Vitale, R.M., Dogne, J.M., Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII (2008) J Med Chem, 51, pp. 3230-3237
Rami, M., Cecchi, A., Montero, J.L., Carbonic anhydrase inhibitors: design of membrane-impermeant copper(II) complexes of DTPA-, DOTA-, and TETA-tailed sulfonamides targeting the tumor-associated transmembrane isoform IX (2008) ChemMedChem, 3, pp. 1780-1788
Vomasta, D., Innocenti, A., Konig, B., Supuran, C.T., Carbonic anhydrase inhibitors: two-prong versus mono-prong inhibitors of isoforms I, II, IX, and XII exemplified by photochromic cis-1,2-alpha-dithienylethene derivatives (2009) Bioorg Med Chem Lett, 19, pp. 1283-1286
Carta, F., Maresca, A., Scozzafava, A., Vullo, D., Supuran, C.T., Carbonic anhydrase inhibitors. Diazenylbenzenesulfonamides are potent and selective inhibitors of the tumor-associated isozymes IX and XII over the cytosolic isoforms I and II (2009) Bioorg Med Chem, 17, pp. 7093-7099
Brzozowski, Z., Slawinski, J., Saczewski, F., Innocenti, A., Supuran, C.T., Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides (2010) Eur J Med Chem, 45, pp. 2396-2404
Marques, S.M., Enyedy, E.A., Supuran, C.T., Krupenko, N.I., Krupenko, S.A., Santos, M.A., Pteridine-sulfonamide conjugates as dual inhibitors of carbonic anhydrases and dihydrofolate reductase with potential antitumor activity (2010) Bioorg Med Chem, 18, pp. 5081-5089
Buller, F., Steiner, M., Frey, K., Selection of carbonic anhydrase IX inhibitors from one million DNA-encoded compounds (2011) ACS Chem Biol, 6, pp. 336-344
Rami, M., Maresca, A., Smaine, F.Z., Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII (2011) Bioorg Med Chem Lett, 21, pp. 2975-2979
Carta, F., Garaj, V., Maresca, A., Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: solution and X-ray crystallographic studies (2011) Bioorg Med Chem, 19, pp. 3105-3119
Morris, J.C., Chiche, J., Grellier, C., Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors (2011) J Med Chem, 54, pp. 6905-6918
Groves, K., Bao, B., Zhang, J., Synthesis and evaluation of near-infrared fluorescent sulfonamide derivatives for imaging of hypoxia-induced carbonic anhydrase IX expression in tumors (2012) Bioorg Med Chem Lett, 22, pp. 653-657
Can, D., Spingler, B., Schmutz, P., [(Cp-R)M(CO)3] (M = Re or 99mTc) Arylsulfonamide, arylsulfamide, and arylsulfamate conjugates for selective targeting of human carbonic anhydrase IX (2012) Angew Chem Int Ed Engl, 51, pp. 3354-3357
Gieling, R.G., Babur, M., Mamnani, L., Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts (2012) J Med Chem, 55, pp. 5591-5600
Winum, J.Y., Carta, F., Ward, C., Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines (2012) Bioorg Med Chem Lett, 22, pp. 4681-4685
D'Ambrosio, K., Smaine, F.Z., Carta, F., De Simone, G., Winum, J.Y., Supuran, C.T., Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups (2012) J Med Chem, 55, pp. 6776-6783
Guzel-Akdemir, O., Akdemir, A., Isik, S., Vullo, D., Supuran, C.T., o-Benzenedisulfonimido-sulfonamides are potent inhibitors of the tumor-associated carbonic anhydrase isoforms CA IX and CA XII (2013) Bioorg Med Chem, 21, pp. 1386-1391
Saada, M.C., Ombouma, J., Montero, J.L., Supuran, C.T., Winum, J.Y., Thiol-ene click chemistry for the synthesis of highly effective glycosyl sulfonamide carbonic anhydrase inhibitors (2013) Chem Commun (Camb), 49, pp. 5699-5701
Akdemir, A., Guzel-Akdemir, O., Scozzafava, A., Capasso, C., Supuran, C.T., Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides (2013) Bioorg Med Chem, 21, pp. 5228-5232
Rami, M., Dubois, L., Parvathaneni, N.K., Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates (2013) J Med Chem, 56, pp. 8512-8520
Sethi, K.K., Verma, S.M., Tanc, M., Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties (2014) Bioorg Med Chem, 22, pp. 1586-1595
Khloya, P., Celik, G., SitaRam, Vullo, D., Supuran, C.T., Sharma, P.K., 4-Functionalized 1,3-diarylpyrazoles bearing benzenesulfonamide moiety as selective potent inhibitors of the tumor associated carbonic anhydrase isoforms IX and XII (2014) Eur J Med Chem, 76, pp. 284-290
Krall, N., Pretto, F., Decurtins, W., Bernardes, G.J., Supuran, C.T., Neri, D., A small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors (2014) Angew Chem Int Ed Engl, 53, pp. 4231-4235
Moeker, J., Peat, T.S., Bornaghi, L.F., Vullo, D., Supuran, C.T., Poulsen, S.A., Cyclic secondary sulfonamides: unusually good inhibitors of cancer-related carbonic anhydrase enzymes (2014) J Med Chem, 57, pp. 3522-3531
Rosatelli, E., Carotti, A., Ceruso, M., Supuran, C.T., Gioiello, A., Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors (2014) Bioorg Med Chem Lett, 24, pp. 3422-3425
Pala, N., Micheletto, L., Sechi, M., Carbonic anhydrase inhibition with benzenesulfonamides and tetrafluorobenzenesulfonamides obtained via click chemistry (2014) ACS Med Chem Lett, 5, pp. 927-930
Ghorab, M.M., Ceruso, M., Alsaid, M.S., Nissan, Y.M., Arafa, R.K., Supuran, C.T., Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: synthesis, cytotoxic activity and molecular modeling (2014) Eur J Med Chem, 87, pp. 186-196
Mahon, B.P., Hendon, A.M., Driscoll, J.M., Saccharin: a lead compound for structure-based drug design of carbonic anhydrase IX inhibitors (2015) Bioorg Med Chem, 23, pp. 849-854
Dilworth, J.R., Pascu, S.I., Waghorn, P.A., Synthesis of sulfonamide conjugates of Cu(II), Ga(III), In(III), Re(V) and Zn(II) complexes: carbonic anhydrase inhibition studies and cellular imaging investigations (2015) Dalton Trans, 44, pp. 4859-4873
Ceruso, M., Antel, S., Scozzafava, A., Supuran, C.T., Synthesis and inhibition potency of novel ureido benzenesulfonamides incorporating GABA as tumor-associated carbonic anhydrase IX and XII inhibitors (2016) J Enzyme Inhib Med Chem, 31, pp. 205-211
Carta, F., Osman, S.M., Vullo, D., Poly(amidoamine) dendrimers with carbonic anhydrase inhibitory activity and antiglaucoma action (2015) J Med Chem, 58, pp. 4039-4045
Carta, F., Ferraroni, M., Scozzafava, A., Supuran, C.T., Fluorescent sulfonamide carbonic anhydrase inhibitors incorporating 1,2,3-triazole moieties: kinetic and X-ray crystallographic studies (2016) Bioorg Med Chem, 24, pp. 104-112
Cornelio, B., Laronze-Cochard, M., Ceruso, M., 4-Arylbenzenesulfonamides as human carbonic anhydrase inhibitors (hCAIs): synthesis by Pd nanocatalyst-mediated Suzuki-Miyaura reaction, enzyme inhibition, and X-ray crystallographic studies (2016) J Med Chem, 59, pp. 721-732
Lomelino, C.L., Mahon, B.P., McKenna, R., Carta, F., Supuran, C.T., Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111 (2016) Bioorg Med Chem, 24, pp. 976-981
Chandak, N., Ceruso, M., Supuran, C.T., Sharma, P.K., Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII (2016) Bioorg Med Chem, 24, pp. 2882-2886
Akocak, S., Alam, M.R., Shabana, A.M., PEGylated bis-sulfonamide carbonic anhydrase inhibitors can efficiently control the growth of several carbonic anhydrase IX-expressing carcinomas (2016) J Med Chem, 59, pp. 5077-5088
Mujumdar, P., Teruya, K., Tonissen, K.F., An unusual natural product primary sulfonamide: synthesis, carbonic anhydrase inhibition, and protein X-ray structures of psammaplin C (2016) J Med Chem, 59, pp. 5462-5470
Coviello, V., Marchi, B., Sartini, S., 1,2-Benzisothiazole derivatives bearing 4-, 5-, or 6-alkyl/arylcarboxamide moieties inhibit carbonic anhydrase isoform IX (CAIX) and cell proliferation under hypoxic conditions (2016) J Med Chem, 59, pp. 6547-6552
Nocentini, A., Vullo, D., Bartolucci, G., Supuran, C.T., N-Nitrosulfonamides: a new chemotype for carbonic anhydrase inhibition (2016) Bioorg Med Chem, 24, pp. 3612-3617
Gul, H.I., Mete, E., Eren, S.E., Sakagami, H., Yamali, C., Supuran, C.T., Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4,5-dihydro-pyrazol-1-yl]benzenesulfonamides (2017) J Enzyme Inhib Med Chem, 32, pp. 169-175
Melis, C., Meleddu, R., Angeli, A., Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors (2017) J Enzyme Inhib Med Chem, 32, pp. 68-73
van Kuijk, S.J., Parvathaneni, N.K., Niemans, R., New approach of delivering cytotoxic drugs towards CAIX expressing cells: a concept of dual-target drugs (2017) Eur J Med Chem, 127, pp. 691-702
Nocentini, A., Ferraroni, M., Carta, F., Benzenesulfonamides incorporating flexible triazole moieties are highly effective carbonic anhydrase inhibitors: synthesis and kinetic, crystallographic, computational, and intraocular pressure lowering investigations (2016) J Med Chem, 59, pp. 10692-10704
Ivanova, J., Balode, A., Zalubovskis, R., 5-Substituted-benzylsulfanyl-thiophene-2-sulfonamides with effective carbonic anhydrase inhibitory activity: solution and crystallographic investigations (2017) Bioorg Med Chem, 25, pp. 857-863
Carta, F., Birkmann, A., Pfaff, T., Lead development of thiazolylsulfonamides with carbonic anhydrase inhibitory action (2017) J Med Chem, 60, pp. 3154-3164
Bragagni, M., Carta, F., Osman, S.M., AlOthman, Z., Supuran, C.T., Synthesis of an acridine orange sulfonamide derivative with potent carbonic anhydrase IX inhibitory action (2017) J Enzyme Inhib Med Chem, 32, pp. 701-706
Guzel, O., Maresca, A., Scozzafava, A., Salman, A., Balaban, A.T., Supuran, C.T., Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII (2009) Bioorg Med Chem Lett, 19, pp. 2931-2934
Bozdag, M., Ferraroni, M., Nuti, E., Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies (2014) Bioorg Med Chem, 22, pp. 334-340
Leitans, J., Sprudza, A., Tanc, M., 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies (2013) Bioorg Med Chem, 21, pp. 5130-5138
Carta, F., Vullo, D., Osman, S.M., AlOthman, Z., Supuran, C.T., Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs (2017) Bioorg Med Chem, 25, pp. 2569-2576
Angeli, A., Carta, F., Bartolucci, G., Supuran, C.T., Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors (2017) Bioorg Med Chem, 25, pp. 3567-3573
Abdoli, M., Angeli, A., Bozdag, M., Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides (2017) J Enzyme Inhib Med Chem, 32, pp. 1071-1078
Angeli, A., Abdel-Aziz, A.A., Nocentini, A., El-Azab, A.S., Gratteri, P., Supuran, C.T., Synthesis and carbonic anhydrase inhibition of polycyclic imides incorporating N-benzenesulfonamide moieties (2017) Bioorg Med Chem, 25, pp. 5373-5379
Kumar, R., Sharma, V., Bua, S., Supuran, C.T., Sharma, P.K., Synthesis and biological evaluation of benzenesulphonamide-bearing 1,4,5-trisubstituted-1,2,3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity (2017) J Enzyme Inhib Med Chem, 32, pp. 1187-1194
Angeli, A., Tanini, D., Peat, T.S., Discovery of new selenoureido analogues of 4-(4-fluorophenylureido)benzenesulfonamide as carbonic anhydrase inhibitors (2017) ACS Med Chem Lett, 8, pp. 963-968
Ramya, P.V.S., Angapelly, S., Angeli, A., Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors (2017) J Enzyme Inhib Med Chem, 32, pp. 1274-1281
Winum, J.Y., Pastorekova, S., Jakubickova, L., Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates (2005) Bioorg Med Chem Lett, 15, pp. 579-584
Colinas, P.A., Bravo, R.D., Vullo, D., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I and II, and extracellular isoforms IV, IX, and XII with sulfamides incorporating sugar moieties (2007) Bioorg Med Chem Lett, 17, pp. 5086-5090
Ombouma, J., Vullo, D., Dumy, P., Supuran, C.T., Winum, J.Y., Carbonic anhydrase glycoinhibitors belonging to the aminoxysulfonamide series (2015) ACS Med Chem Lett, 6, pp. 819-821
Vitale, R.M., Alterio, V., Innocenti, A., Carbonic anhydrase inhibitors. Comparison of aliphatic sulfamate/bis-sulfamate adducts with isozymes II and IX as a platform for designing tight-binding, more isoform-selective inhibitors (2009) J Med Chem, 52, pp. 5990-5998
Lopez, M., Paul, B., Hofmann, A., S-glycosyl primary sulfonamides: a new structural class for selective inhibition of cancer-associated carbonic anhydrases (2009) J Med Chem, 52, pp. 6421-6432
Kohler, K., Hillebrecht, A., Schulze Wischeler, J., Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste (2007) Angew Chem Int Ed Engl, 46, pp. 7697-7699
De Simone, G., Langella, E., Esposito, D., Insights into the binding mode of sulphamates and sulphamides to hCA II: crystallographic studies and binding free energy calculations (2017) J Enzyme Inhib Med Chem, 32, pp. 1002-1011
Alterio, V., Esposito, D., Monti, S.M., Supuran, C.T., De Simone, G., Crystal structure of the human carbonic anhydrase II adduct with 1-(4-sulfamoylphenyl-ethyl)-2,4,6-triphenylpyridinium perchlorate, a membrane-impermeant, isoform selective inhibitor (2018) J Enzyme Inhib Med Chem, 33, pp. 151-157
Pacchiano, F., Aggarwal, M., Avvaru, B.S., Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency (2010) Chem Commun (Camb), 46, pp. 8371-8373
Innocenti, A., Vullo, D., Scozzafava, A., Casey, J.R., Supuran, C., Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates (2005) Bioorg Med Chem Lett, 15, pp. 573-578
Langella, E., D'Ambrosio, K., D'Ascenzio, M., A combined crystallographic and theoretical study explains the capability of carboxylic acids to adopt multiple binding modes in the active site of carbonic anhydrases (2016) Chemistry, 22, pp. 97-100
D'Ambrosio, K., Carradori, S., Monti, S.M., Out of the active site binding pocket for carbonic anhydrase inhibitors (2015) Chem Commun (Camb), 51, pp. 302-305
Maresca, A., Akyuz, G., Osman, S.M., AlOthman, Z., Supuran, C.T., Inhibition of mammalian carbonic anhydrase isoforms I-XIV with a series of phenolic acid esters (2015) Bioorg Med Chem, 23, pp. 7181-7188
Innocenti, A., Beyza Ozturk Sarikaya, S., Gulcin, I., Supuran, C.T., Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids (2010) Bioorg Med Chem, 18, pp. 2159-2164
Martin, D.P., Cohen, S.M., Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors (2012) Chem Commun (Camb), 48, pp. 5259-5261
Maresca, A., Temperini, C., Vu, H., Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors (2009) J Am Chem Soc, 131, pp. 3057-3062
Abdel-Aziz, A.A., El-Azab, A.S., Ceruso, M., Supuran, C.T., Carbonic anhydrase inhibitory activity of sulfonamides and carboxylic acids incorporating cyclic imide scaffolds (2014) Bioorg Med Chem Lett, 24, pp. 5185-5189
El-Azab, A.S., Abdel-Aziz, A.A., Ayyad, R.R., Ceruso, M., Supuran, C.T., Inhibition of carbonic anhydrase isoforms I, II, IV, VII and XII with carboxylates and sulfonamides incorporating phthalimide/phthalic anhydride scaffolds (2016) Bioorg Med Chem, 24, pp. 20-25
Barresi, E., Salerno, S., Marini, A.M., Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII (2016) Bioorg Med Chem, 24, pp. 921-927
Cvijetic, I.N., Tanc, M., Juranic, I.O., Verbic, T.Z., Supuran, C.T., Drakulic, B.J., 5-Aryl-1H-pyrazole-3-carboxylic acids as selective inhibitors of human carbonic anhydrases IX and XII (2015) Bioorg Med Chem, 23, pp. 4649-4659
Cadoni, R., Pala, N., Lomelino, C., Exploring heteroaryl-pyrazole carboxylic acids as human carbonic anhydrase XII inhibitors (2017) ACS Med Chem Lett, 8, pp. 941-946
Boztas, M., Cetinkaya, Y., Topal, M., Synthesis and carbonic anhydrase isoenzymes I, II, IX, and XII inhibitory effects of dimethoxybromophenol derivatives incorporating cyclopropane moieties (2015) J Med Chem, 58, pp. 640-650
Carradori, S., De Monte, C., D'Ascenzio, M., Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII: a new scaffold for designing isoform-selective inhibitors (2013) Bioorg Med Chem Lett, 23, pp. 6759-6763
Durdagi, S., Senturk, M., Ekinci, D., Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site (2011) Bioorg Med Chem, 19, pp. 1381-1389
Innocenti, A., Gulcin, I., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV (2010) Bioorg Med Chem Lett, 20, pp. 5050-5053
Karioti, A., Ceruso, M., Carta, F., Bilia, A.R., Supuran, C.T., New natural product carbonic anhydrase inhibitors incorporating phenol moieties (2015) Bioorg Med Chem, 23, pp. 7219-7225
Scozzafava, A., Passaponti, M., Supuran, C.T., Gulcin, I., Carbonic anhydrase inhibitors: guaiacol and catechol derivatives effectively inhibit certain human carbonic anhydrase isoenzymes (hCA I, II, IX and XII) (2015) J Enzyme Inhib Med Chem, 30, pp. 586-591
Yamali, C., Gul, H.I., Sakagami, H., Supuran, C.T., Synthesis and bioactivities of halogen bearing phenolic chalcones and their corresponding bis Mannich bases (2016) J Enzyme Inhib Med Chem, 31, pp. 125-131
Abellan-Flos, M., Tanc, M., Supuran, C.T., Vincent, S.P., Exploring carbonic anhydrase inhibition with multimeric coumarins displayed on a fullerene scaffold (2015) Org Biomol Chem, 13, pp. 7445-7451
Bonneau, A., Maresca, A., Winum, J.Y., Supuran, C.T., Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonic anhydrase inhibitors (2013) J Enzyme Inhib Med Chem, 28, pp. 397-401
Bozdag, M., Alafeefy, A.M., Altamimi, A.M., Vullo, D., Carta, F., Supuran, C.T., Coumarins and other fused bicyclic heterocycles with selective tumor-associated carbonic anhydrase isoforms inhibitory activity (2017) Bioorg Med Chem, 25, pp. 677-683
Bua, S., Di Cesare Mannelli, L., Vullo, D., Design and synthesis of novel nonsteroidal anti-inflammatory drugs and carbonic anhydrase inhibitors hybrids (NSAIDs-CAIs) for the treatment of rheumatoid arthritis (2017) J Med Chem, 60, pp. 1159-1170
Davis, R.A., Vullo, D., Maresca, A., Supuran, C.T., Poulsen, S.A., Natural product coumarins that inhibit human carbonic anhydrases (2013) Bioorg Med Chem, 21, pp. 1539-1543
Kucukbay, F.Z., Kucukbay, H., Tanc, M., Supuran, C.T., Synthesis and carbonic anhydrase inhibitory properties of amino acid: coumarin/quinolinone conjugates incorporating glycine, alanine and phenylalanine moieties (2016) J Enzyme Inhib Med Chem, 31, pp. 1198-1202
Nocentini, A., Carta, F., Ceruso, M., Bartolucci, G., Supuran, C.T., Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII (2015) Bioorg Med Chem, 23, pp. 6955-6966
Sharma, A., Tiwari, M., Supuran, C.T., Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX (2014) J Enzyme Inhib Med Chem, 29, pp. 292-296
Touisni, N., Maresca, A., McDonald, P.C., Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors (2011) J Med Chem, 54, pp. 8271-8277
Vullo, D., Isik, S., Bozdag, M., Carta, F., Supuran, C.T., 7-Amino-3,4-dihydro-1H-quinolin-2-one, a compound similar to the substituted coumarins, inhibits alpha-carbonic anhydrases without hydrolysis of the lactam ring (2015) J Enzyme Inhib Med Chem, 30, pp. 773-777
Grandane, A., Tanc, M., Di Cesare Mannelli, L., 6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells (2015) J Med Chem, 58, pp. 3975-3983
Nocentini, A., Ceruso, M., Carta, F., Supuran, C.T., 7-Aryl-triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrase IX and XII (2016) J Enzyme Inhib Med Chem, 31, pp. 1226-1233
Pustenko, A., Stepanovs, D., Zalubovskis, R., 3H-1,2-benzoxathiepine 2,2-dioxides: a new class of isoform-selective carbonic anhydrase inhibitors (2017) J Enzyme Inhib Med Chem, 32, pp. 767-775
Tanc, M., Carta, F., Bozdag, M., Scozzafava, A., Supuran, C.T., 7-Substituted-sulfocoumarins are isoform-selective, potent carbonic anhydrase II inhibitors (2013) Bioorg Med Chem, 21, pp. 4502-4510
Tars, K., Vullo, D., Kazaks, A., Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases (2013) J Med Chem, 56, pp. 293-300
Falsini, M., Squarcialupi, L., Catarzi, D., 3-Hydroxy-1H-quinazoline-2,4-dione as a new scaffold to develop potent and selective inhibitors of the tumor-associated carbonic anhydrases IX and XII (2017) J Med Chem, 60, pp. 6428-6439
Liu, F., Martin-Mingot, A., Lecornue, F., Carbonic anhydrases inhibitory effects of new benzenesulfonamides synthesized by using superacid chemistry (2012) J Enzyme Inhib Med Chem, 27, pp. 886-891
Compain, G., Martin-Mingot, A., Maresca, A., Thibaudeau, S., Supuran, C.T., Superacid synthesis of halogen containing N-substituted-4-aminobenzene sulfonamides: new selective tumor-associated carbonic anhydrase inhibitors (2013) Bioorg Med Chem, 21, pp. 1555-1563
Metayer, B., Mingot, A., Vullo, D., Supuran, C.T., Thibaudeau, S., New superacid synthesized (fluorinated) tertiary benzenesulfonamides acting as selective hCA IX inhibitors: toward a new mode of carbonic anhydrase inhibition by sulfonamides (2013) Chem Commun (Camb), 49, pp. 6015-6017
Metayer, B., Martin-Mingot, A., Vullo, D., Supuran, C.T., Thibaudeau, S., Superacid synthesized tertiary benzenesulfonamides and benzofuzed sultams act as selective hCA IX inhibitors: toward understanding a new mode of inhibition by tertiary sulfonamides (2013) Org Biomol Chem, 11, pp. 7540-7549
Le Darz, A., Mingot, A., Bouazza, F., Fluorinated pyrrolidines and piperidines incorporating tertiary benzenesulfonamide moieties are selective carbonic anhydrase II inhibitors (2015) J Enzyme Inhib Med Chem, 30, pp. 737-745
D'Ascenzio, M., Carradori, S., De Monte, C., Secci, D., Ceruso, M., Supuran, C.T., Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII (2014) Bioorg Med Chem, 22, pp. 1821-1831
De Monte, C., Carradori, S., Secci, D., Cyclic tertiary sulfamates: selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives (2014) Eur J Med Chem, 84, pp. 240-246
Carradori, S., Mollica, A., Ceruso, M., New amide derivatives of probenecid as selective inhibitors of carbonic anhydrase IX and XII: biological evaluation and molecular modelling studies (2015) Bioorg Med Chem, 23, pp. 2975-2981
Mollica, A., Costante, R., Akdemir, A., Exploring new probenecid-based carbonic anhydrase inhibitors: synthesis, biological evaluation and docking studies (2015) Bioorg Med Chem, 23, pp. 5311-5318
D'Ascenzio, M., Guglielmi, P., Carradori, S., Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms (2017) J Enzyme Inhib Med Chem, 32, pp. 51-59
Parkkila, S., Innocenti, A., Kallio, H., Hilvo, M., Scozzafava, A., Supuran, C.T., The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian alpha-carbonic anhydrase isoforms (2009) Bioorg Med Chem Lett, 19, pp. 4102-4106
Dubois, L., Peeters, S., Lieuwes, N.G., Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation (2011) Radiother Oncol, 99, pp. 424-431
Ward, C., Meehan, J., Mullen, P., Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models (2015) Oncotarget, 6, pp. 24856-24870
Meehan, J., Ward, C., Turnbull, A., Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells (2017) Oncotarget, 8, pp. 42857-42875
Andreucci, E., Peppicelli, S., Carta, F., Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis (2017) J Mol Med (Berl), 95, pp. 1341-1353
Gieling, R.G., Parker, C.A., De Costa, L.A., Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells in vitro (2013) J Enzyme Inhib Med Chem, 28, pp. 360-369
Bryant, J.L., Gieling, R.G., Meredith, S.L., Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer (2018) Int J Cancer, 142, pp. 191-201
Logsdon, D.P., Grimard, M., Luo, M., Regulation of HIF1alpha under hypoxia by APE1/Ref-1 impacts CA9 expression: dual targeting in patient-derived 3D pancreatic cancer models (2016) Mol Cancer Ther, 15, pp. 2722-2732
Dubois, L., Douma, K., Supuran, C.T., Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors (2007) Radiother Oncol, 83, pp. 367-373
Dubois, L., Lieuwes, N.G., Maresca, A., Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model (2009) Radiother Oncol, 92, pp. 423-428
Akurathi, V., Dubois, L., Lieuwes, N.G., Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia (2010) Nucl Med Biol, 37, pp. 557-564
Peeters, S.G., Dubois, L., Lieuwes, N.G., [(18)F]VM4-037 MicroPET imaging and biodistribution of two in vivo CAIX-expressing tumor models (2015) Mol Imaging Biol, 17, pp. 615-619
Pan, J., Lau, J., Mesak, F., Synthesis and evaluation of 18F-labeled carbonic anhydrase IX inhibitors for imaging with positron emission tomography (2014) J Enzyme Inhib Med Chem, 29, pp. 249-255
Lau, J., Liu, Z., Lin, K.S., Trimeric radiofluorinated sulfonamide derivatives to achieve in vivo selectivity for carbonic anhydrase IX-targeted PET imaging (2015) J Nucl Med, 56, pp. 1434-1440
Lau, J., Zhang, Z., Jenni, S., PET imaging of carbonic anhydrase IX expression of HT-29 tumor xenograft mice with (68)Ga-labeled benzenesulfonamides (2016) Mol Pharm, 13, pp. 1137-1146
Sneddon, D., Niemans, R., Bauwens, M., Synthesis and in vivo biological evaluation of (68)Ga-labeled carbonic anhydrase IX targeting small molecules for positron emission tomography (2016) J Med Chem, 59, pp. 6431-6443
Zhang, Z., Lau, J., Zhang, C., Design, synthesis and evaluation of 18F-labeled cationic carbonic anhydrase IX inhibitors for PET imaging (2017) J Enzyme Inhib Med Chem, 32, pp. 722-730
Margheri, F., Ceruso, M., Carta, F., Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium (2016) J Enzyme Inhib Med Chem, 31, pp. 60-63
Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one
Human carbonic anhydrase (CA) IX is a tumor-associated protein, since it is scarcely present in normal tissues, but highly overexpressed in a large number of solid tumors, where it actively contributes to survival and metastatic spread of tumor cells. Due to these features, the characterization of its biochemical, structural, and functional features for drug design purposes has been extensively carried out, with consequent development of several highly selective small molecule inhibitors and monoclonal antibodies to be used for different purposes. Aim of this review is to provide a comprehensive state-of-the-art of studies performed on this enzyme, regarding structural, functional, and biomedical aspects, as well as the development of molecules with diagnostic and therapeutic applications for cancer treatment. A brief description of additional pharmacologic applications for CA IX inhibition in other diseases, such as arthritis and ischemia, is also provided. © 2018 Wiley Periodicals, Inc.
Human carbonic anhydrase (CA) IX is a tumor-associated protein, since it is scarcely present in normal tissues, but highly overexpressed in a large number of solid tumors, where it actively contributes to survival and metastatic spread of tumor cells. Due to these features, the characterization of its biochemical, structural, and functional features for drug design purposes has been extensively carried out, with consequent development of several highly selective small molecule inhibitors and monoclonal antibodies to be used for different purposes. Aim of this review is to provide a comprehensive state-of-the-art of studies performed on this enzyme, regarding structural, functional, and biomedical aspects, as well as the development of molecules with diagnostic and therapeutic applications for cancer treatment. A brief description of additional pharmacologic applications for CA IX inhibition in other diseases, such as arthritis and ischemia, is also provided. © 2018 Wiley Periodicals, Inc.
Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one
Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one
Other filter: ([btitle,keywords] "Antibodies" OR [btit ...
Di Fiore A, Supuran CT, Scaloni A, De Simone G
* Post-translational modifications in tumor-associated carbonic anhydrases (22 views)
Amino Acids (ISSN: 0939-4451linking, 1438-2199electronic), 2022 Apr; 54(4): 543-558.
Impact Factor: 3.46
View Export to BibTeX Export to EndNote
Moreira M, Ruggiero A, Iaccarino E, Barra G, Sandomenico A, Ruvo M, Berisio R
* A structure-based approach for the development of a bicyclic peptide acting as a miniaturized anti-CD55 antibody (31 views) (PDF 16 views)
Int J Biol Macromol (ISSN: 0141-8130linking, 1879-0003electronic), 2021 May 17; 182: 1455-1462.
Impact Factor: 6.95
View Export to BibTeX Export to EndNote
Sivaccumar JP, Leonardi A, Iaccarino E, Corvino G, Sanguigno L, Chambery A, Russo R, Valletta M, Latino D, Capasso D, Doti N, Ruvo M, Sandomenico A
* Development of a New Highly Selective Monoclonal Antibody against Preferentially Expressed Antigen in Melanoma (PRAME) and Identification of the Target Epitope by Bio-Layer Interferometry (17 views)
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic, 1661-6596), 2021 Mar 20; 22(6): N/D-N/D.
Impact Factor: 4.556
View Export to BibTeX Export to EndNote
Langella E, Buonanno M, De Simone G, Monti SM
* Intrinsically disordered features of carbonic anhydrase IX proteoglycan-like domain (30 views)
Cell Mol Life Sci (ISSN: 1420-682xlinking), 2021 Mar; 78(5): 2059-2067.
Impact Factor: 9.261
View Export to BibTeX Export to EndNote
Gogliettino M, Cocca E, Sandomenico A, Gratino L, Iaccarino E, Calvanese L, Rossi M, Palmieri G
* Selective inhibition of acylpeptide hydrolase in SAOS-2 osteosarcoma cells: is this enzyme a viable anticancer target? (20 views)
Mol Biol Rep (ISSN: 0301-4851linking), 2021 Feb; 48(2): 1505-1519.
Impact Factor: 2.316
View Export to BibTeX Export to EndNote
Sivaccumar J, Sandomenico A, Vitagliano L, Ruvo M
* Monoclonal Antibodies: A Prospective and Retrospective View (71 views)
Curr Med Chem (ISSN: 0929-8673linking, 1875-533xelectronic), 2021; 28(3): 435-471.
Impact Factor: 4.184
View Export to BibTeX Export to EndNote
Canassa-deleo T, Campo VL, Rodrigues LC, Marchiori MF, Fuzo C, Brigido MM, Sandomenico A, Ruvo M, Maranhao AQ, Dias-baruffi M
* Multifaceted antibodies development against synthetic alpha-dystroglycan mucin glycopeptide as promising tools for dystroglycanopathies diagnostic (157 views)
Glycoconj J (ISSN: 0282-0080linking), 2020 Feb; 37(1): 77-93.
Impact Factor: 2.197
View Export to BibTeX Export to EndNote
Langella E, Buonanno M, De Simone G, Monti SM
* Intrinsically disordered features of carbonic anhydrase IX proteoglycan-like domain (94 views)
Cell Mol Life Sci (ISSN: 1420-682xlinking), 2020; 21: 8405-8405.
Impact Factor: 6.496
View Export to BibTeX Export to EndNote
Di Stasi R, De Rosa L, Diana D, Fattorusso R, D'Andrea LD
* Human Recombinant VEGFR2D4 Biochemical Characterization to Investigate Novel Anti-VEGFR2D4 Antibodies for Allosteric Targeting of VEGFR2 (287 views)
Mol Biotechnol (ISSN: 1073-6085linking, 1559-0305electronic), 2019 Apr 26; 61(7): 513-520.
Impact Factor: 2.275
View Export to BibTeX Export to EndNote
Foca G, Iaccarino E, Foca A, Sanguigno L, Untiveros G, Cuevas-nunez M, Strizzi L, Leonardi A, Ruvo M, Sandomenico A
* Development of conformational antibodies targeting Cripto-1 with neutralizing effects in vitro (535 views)
Biochimie (ISSN: 0300-9084linking, 1638-6183electronic), 2019 Mar; 158: 246-256.
Impact Factor: 3.787
View Export to BibTeX Export to EndNote
De Simone G
* Targeted treatment of anaerobic cancer. Patent evaluation of US2016279084 and US2017056350 (225 views)
Expert Opin Ther Pat (ISSN: 1744-7674electronic, 1354-3776linking), 2019 Jan; 29(1): 1-6.
Impact Factor: 3.699
View Export to BibTeX Export to EndNote
Langella E, Buonanno M, Vullo D, Dathan N, Leone M, Supuran C, De Simone G, Monti SM
* Biochemical, biophysical and molecular dynamics studies on the proteoglycan-like domain of carbonic anhydrase IX (317 views)
Cell Mol Life Sci (ISSN: 1420-682xlinking), 2018 Sep; 75(17): 3283-3296.
Impact Factor: 6.721
View Export to BibTeX Export to EndNote
Mishra CB, Kumari S, Angeli A, Bua S, Buonanno M, Monti SM, Tiwari M, Supuran CT
* Discovery of potent anti-convulsant carbonic anhydrase inhibitors: Design, synthesis, in vitro and in vivo appraisal (234 views)
Eur J Med Chem (ISSN: 0223-5234linking, 1768-3254electronic), 2018 Aug 5; 156: 430-443.
Impact Factor: 4.816
View Export to BibTeX Export to EndNote
Calvanese L, Foca A, Sandomenico A, Foca G, Caporale A, Doti N, Iaccarino E, Leonardi A, D'Auria G, Ruvo M, Falcigno L
* Structural insights into the interaction of a monoclonal antibody and Nodal peptides by STD-NMR spectroscopy (499 views)
Bioorg Med Chem (ISSN: 0968-0896, 1464-3391, 0968-0896linking), 2017 Dec 15; 25(24): 6589-6596.
Impact Factor: 2.881
View Export to BibTeX Export to EndNote
Maglio O, Costanzo S, Cercola R, Zambrano G, Mauro M, Battaglia R, Ferrini G, Nastri F, Pavone V, Lombardi A
* A Quartz Crystal Microbalance Immunosensor for Stem Cell Selection and Extraction (507 views) (PDF 151 views)
Sensors (ISSN: 1424-8220, 1424-3210, 1424-8220linking), 2017 Nov 28; 17(12): N/D-N/D.
Impact Factor: 2.475
View Export to BibTeX Export to EndNote
Buonanno M, Langella E, Zambrano N, Succoio M, Sasso E, Alterio V, Di Fiore A, Sandomenico A, Supuran CT, Scaloni A, Monti SM, De Simone G
* Disclosing the Interaction of Carbonic Anhydrase IX with Cullin-Associated NEDD8-Dissociated Protein 1 by Molecular Modeling and Integrated Binding Measurements (279 views)
Acs Chem Biol (ISSN: 1554-8929), 2017 Apr 19; N/D: N/D-N/D.
Impact Factor: 4.592
View Export to BibTeX Export to EndNote
Leiria Campo V, Riul TB, Oliveira Bortot L, Martins-teixeira MB, Fiori Marchiori M, Iaccarino E, Ruvo M, Dias-baruffi M, Carvalho I
* A Synthetic MUC1 Glycopeptide Bearing betaGalNAc-Thr as a Tn Antigen Isomer Induces the Production of Antibodies against Tumor Cells (1299 views)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-4227linking), 2017 Mar 16; 18(6): 527-538.
Impact Factor: 2.774
View Export to BibTeX Export to EndNote
Sandomenico A, Focà A, Sanguigno L, Caporale A, Focà G, Pignalosa A, Corvino G, Caragnano A, Beltrami AP, Antoniali G, Tell G, Leonardi A, Ruvo M
* Monoclonal antibodies against pools of mono- and polyacetylated peptides selectively recognize acetylated lysines within the context of the original antigen (391 views) (PDF 219 views)
Mabs-Austin (ISSN: 1942-0862), 2016 Aug; 8: 1575-1589.
Impact Factor: 4.881
View Export to BibTeX Export to EndNote
Quero G, Consales M, Severino R, Vaiano P, Boniello A, Sandomenico A, Ruvo M, Borriello A, Diodato L, Zuppolini S, Giordano M, Nettore IC, Mazzarella C, Colao A, Macchia PE, Santorelli F, Cutolo A, Cusano A
* Long period fiber grating nano-optrode for cancer biomarker detection (309 views) (PDF 203 views)
Biosens Bioelectron (ISSN: 0956-5663, 1873-4235electronic), 2016 Feb 13; 80: 590-600.
Impact Factor: 7.78
View Export to BibTeX Export to EndNote
Sandomenico A, Leonardi A, Berisio R, Sanguigno L, Foca G, Foca A, Ruggiero A, Doti N, Muscariello L, Barone D, Farina C, Owsianka A, Vitagliano L, Patel AH, Ruvo M
* Generation and characterization of monoclonal antibodies against a cyclic variant of Hepatitis C Virus E2 epitope 412-422 (445 views) (PDF 201 views)
J Virol (ISSN: 0022-538x, 0022-538xlinking), 2016 Jan 27; 90(7): 3745-3759.
Impact Factor: 4.663
View Export to BibTeX Export to EndNote
Bogdanovich S, Kim Y, Mizutani T, Yasuma R, Tudisco L, Cicatiello V, Bastos-carvalho A, Kerur N, Hirano Y, Baffi JZ, Tarallo V, Li S, Yasuma T, Arpitha P, Fowler BJ, Wright CB, Apicella I, Greco A, Brunetti A, Ruvo M, Sandomenico A, Nozaki M, Ijima R, Kaneko H, Ogura Y, Terasaki H, Ambati BK, Leusen JH, Langdon WY, Clark MR, Armour KL, Bruhns P, Verbeek JS, Gelfand BD, De Falco S, Ambati J
* Human IgG1 antibodies suppress angiogenesis in a target-independent manner (557 views)
Signal Transduct Target Ther (ISSN: 2059-3635print), 2016; 1: N/D-N/D.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Palladino P, Aura AM, Spoto G
* Surface plasmon resonance for the label-free detection of Alzheimer's β-amyloid peptide aggregation (528 views)
Anal Bioanal Chem (ISSN: 1618-2642), 2016; 408(3): 849-854.
Impact Factor: 3.431
View Export to BibTeX Export to EndNote
Foca A, Sanguigno L, Foca G, Strizzi L, Iannitti R, Palumbo R, Hendrix MJ, Leonardi A, Ruvo M, Sandomenico A
* New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding (718 views) (PDF 265 views)
Int J Mol Sc (ISSN: 1422-0067, 1661-6596, 1422-0067linking), 2015 Sep 7; 16(9): 21342-21362.
Impact Factor: 3.257
View Export to BibTeX Export to EndNote
Klauzinska M, Bertolette D, Tippireddy S, Strizzi L, Gray PC, Gonzales M, Duroux M, Ruvo M, Wechselberger C, Castro NP, Rangel MC, Focà A, Sandomenico A, Hendrix MJC, Salomon D, Cuttitta F
* Cripto-1: an extracellular protein – connecting the sequestered biological dots (296 views)
Connect Tissue Res (ISSN: 0300-8207), 2015; N/D: N/D-N/D.
Impact Factor: 1.411
View Export to BibTeX Export to EndNote
Lanzillo R, Liuzzi R, Vallefuoco L, Moccia M, Amato L, Vacca G, Vacchiano V, Portella G, Brescia Morra V
* JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level (324 views)
Ther Clin Risk Manag (ISSN: 1178-203x), 2014 Oct 9; 10: 807-814.
Impact Factor: 1.469
View Export to BibTeX Export to EndNote
Gallicchio R, Mansueto G, Simeon V, Nardelli A, Guariglia R, Capacchione D, Soscia E, Pedicini P, Gattozzi D, Musto P, Storto G
* F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma (531 views)
Eur J Haematol (ISSN: 0902-4441), 2014 May; 92(5): 382-389.
Impact Factor: 2.066
View Export to BibTeX Export to EndNote
Rami M, Dubois L, Parvathaneni NK, Alterio V, van Kuijk SJ, Monti SM, Lambin P, De Simone G, Supuran CT, Winum JY
* Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates (546 views)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2013 Nov 14; 56(21): 8512-8520.
Impact Factor: 5.48
View Export to BibTeX Export to EndNote
Lanzillo R, Bonavita S, Quarantelli M, Vacca G, Lus G, Amato L, Carotenuto A, Tedeschi G, Orefice G, Brescia Morra V
* Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice (312 views)
Neurol Sci (ISSN: 1590-1874, 1590-0187, 1590-3478), 2013 Apr; 34(4): 521-528.
Impact Factor: 0.38
View Export to BibTeX Export to EndNote
Calce E, Monfregola L, Sandomenico A, Saviano M, De Luca S
* Fluorescence study for selecting specific ligands toward HER2 receptor: An example of receptor fragment approach (438 views)
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 1768-3254electronic), 2013 Mar; 61: 116-121.
Impact Factor: 3.432
View Export to BibTeX Export to EndNote
Rosa R, Marciano R, Malapelle U, Formisano L, Nappi L, D'Amato C, D'Amato V, Damiano V, Marf G, Del Vecchio S, Zannetti A, Greco A, De Stefano A, Carlomagno C, Veneziani BM, Troncone G, De Placido S, Bianco R
* Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models (672 views)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2013 Jan 1; 19(1): 138-147.
Impact Factor: 8.193
View Export to BibTeX Export to EndNote
Buanne P, Renzone G, Monteleone F, Vitale M, Monti SM, Sandomenico A, Garbi C, Montanaro D, Accardo M, Troncone G, Zatovicova M, Csaderova L, Supuran CT, Pastorekova S, Scaloni A, De Simone G, Zambrano N
* Characterization of carbonic anhydrase ix interactome reveals proteins assisting its nuclear localization in hypoxic cells (393 views)
J Proteome Res (ISSN: 1535-3893), 2013 Jan; 12(1): 282-292.
Impact Factor: 5.001
View Export to BibTeX Export to EndNote
Lanzillo R, Quarantelli M, Bonavita S, Ventrella G, Lus G, Vacca G, Prinster A, Orefice G, Tedeschi G, Brescia Morra V
* Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: A head-to-head retrospective study (400 views)
Acta Neurol Scand (ISSN: 0001-6314, 1600-0404), 2012 Nov; 126(5): 306-314.
Impact Factor: 2.474
View Export to BibTeX Export to EndNote
Tagliamonte M, Marasco D, Ruggiero A, de Stradis A, Tornesello ML, Totrov M, Buonaguro FM, Buonaguro L
* HIV p24 as Scaffold for Presenting Conformational HIV Env Antigens (405 views)
Plosone (ISSN: 1932-6203, 1932-6203electronic, 1932-6203linking), 2012 Sep 17; 7(8): N/D-N/D.
Impact Factor: 3.73
View Export to BibTeX Export to EndNote
Risitano AM, Imbriaco M, Marando L, Seneca E, Soscia E, Malcovati L, Iori AP, Pane F, Notaro R, Matarazzo M
* From perpetual haemosiderinuria to possible iron overload: iron redistribution in paroxysmal nocturnal haemoglobinuria patients on eculizumab by magnetic resonance imaging (359 views)
Br J Haematol (ISSN: 0007-1048, 0007-1048linking, 1365-2141electronic), 2012 Sep; 158(3): 415-418.
Impact Factor: 4.942
View Export to BibTeX Export to EndNote
Pedicini P, Caivano R, Jereczek-Fossa BA, Strigari L, Vischioni B, Alterio D, Cremonesi M, Botta F, Nappi A, Improta G, Storto G, Benassi M, Orecchia R
* Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors (382 views)
Theor Biol Med Model (ISSN: 1742-4682), 2012 Jun 19; 9(1): 23-23.
Impact Factor: 1.461
View Export to BibTeX Export to EndNote
Monti SM, Supuran CT, De Simone G
* Carbonic anhydrase IX as a target for designing novel anticancer drugs (526 views)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2012 Feb; 19(6): 821-830.
Impact Factor: 4.07
View Export to BibTeX Export to EndNote
Troise F, Monti M, Merlino A, Cozzolino F, Fedele C, Russo Krauss I, Sica F, Pucci P, D'Alessio G, De Lorenzo C
* A novel ErbB2 epitope targeted by human antitumor immunoagents (391 views)
Febs Journal (ISSN: 1742-464x), 2011 Apr; 278(7): 1156-1166.
Impact Factor: 3.79
View Export to BibTeX Export to EndNote
Lanzillo R, Orefice G, Prinster A, Ventrella G, Liuzzi R, Scarano V, Florio C, Vacca G, Brunetti A, Alfano B, Brescia Morra V, Bonavita V
* Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapy (314 views) (PDF 221 views)
Neurol Sci (ISSN: 1590-1874, 1590-3478, 1590-1874linking), 2011 Apr; 32(2): 287-292.
Impact Factor: 1.315
View Export to BibTeX Export to EndNote
Palmieri C, Falcone C, Iaccino E, Tuccillo FM, Gaspari M, Trimboli F, De Laurentiis A, Luberto L, Pontoriero M, Pisano A, Vecchio E, Fierro O, Panico M, Larobina M, Gargiulo S, Costa N, Dal Piaz F, Schiavone M, Arra C, Giudice A, Palma G, Barbieri A, Quinto I, Scala G
* In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder (581 views)
Blood (ISSN: 0006-4971, 0006-6497, 0390-6078), 2010 Jul 15; 116(2): 226-238.
Impact Factor: 10.558
View Export to BibTeX Export to EndNote
Alberobello AT, D'Esposito V, Marasco D, Doti N, Ruvo M, Bianco R, Tortora G, Esposito I, Fiory F, Miele C, Beguinot F, Formisano P
* Selective Disruption of Insulin-like Growth Factor-1 (IGF-1) Signaling via Phosphoinositide-dependent Kinase-1 Prevents the Protective Effect of IGF-1 on Human Cancer Cell Death (578 views)
Jbc Papers (ISSN: 0021-9258, 1083-351x, 0021-9258linking), 2010 Feb 26; 285(9): 6563-6572.
Impact Factor: 5.328
View Export to BibTeX Export to EndNote
De Simone G, Supuran CT
* Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target (398 views)
Bba-Gen Subjects (ISSN: 1570-9639, 0006-3002, 0925-4439), 2010 Feb; 1804(2): 404-409.
Impact Factor: 2.773
View Export to BibTeX Export to EndNote
Storto G, De Renzo A, Pellegrino T, Perna F, De Falco T, Erra P, Nardelli A, Speranza A, Klain M, Rotoli B, Pace L
* Assessment of Metabolic Response to Radioimmunotherapy with (90)Y-Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (399 views)
Radiology (ISSN: 0033-8419, 1527-1315, 0033-8419linking), 2010 Jan; 254(1): 245-252.
Impact Factor: 6.069
View Export to BibTeX Export to EndNote
Guler OO, De Simone G, Supuran CT
* Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII (540 views)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2010; 17(15): 1516-1526.
Impact Factor: 4.63
View Export to BibTeX Export to EndNote
Supuran CT, Di Fiore A, Alterio V, Monti SM, De Simone G
* Recent advances in structural studies of the carbonic anhydrase family: The crystal structure of human CA IX and CA XIII (471 views)
Curr Pharm Des Current Pharmaceutical Design (ISSN: 1381-6128, 1873-4286), 2010; 16(29): 3246-3254.
Impact Factor: 4.774
View Export to BibTeX Export to EndNote
Giurato P, Candura A, Grasso G, Spoto G
* In situ identification of organic components of ink used in books from the 1900s by atmospheric pressure matrix assisted laser desorption ionization mass spectrometry (303 views)
Appl Phys A (ISSN: 0947-8396), 2009 Nov; 97(2): 263-269.
Impact Factor: 1.595
View Export to BibTeX Export to EndNote
Alterio V, Hilvo M, Di Fiore A, Supuran CT, Pan P, Parkkila S, Scaloni A, Pastorek J, Pastorekova S, Pedone C, Scozzafava A, Monti SM, De Simone G
* Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX (571 views)
P Natl Acad Sci Usa (ISSN: 0027-8424, 1091-6490, 0027-8424print), 2009 Sep 22; 106(38): 16233-16238.
Impact Factor: 9.432
View Export to BibTeX Export to EndNote
Ragno R, Simeoni S, Castellano S, Vicidomini C, Mai A, Caroli A, Tramontano A, Bonaccini C, Trojer P, Bauer I, Brosch G, Sbardella G
* Small molecule inhibitors of histone arginine methyltransferases: Homology modeling, molecular docking, binding mode analysis, and biological evaluations (781 views)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2007 Mar 22; 50(6): 1241-1253.
Impact Factor: 4.895
View Export to BibTeX Export to EndNote
Palmieri G, Marino M, Salvatore M, Budillon A, Meo G, Caraglia M, Montella L
* Cetuximab is an active treatment of metastatic and chemorefractory thymoma (372 views)
Frontiers In Bioscience (ISSN: 1093-9946, 1093-4715), 2007 Jan 1; 12(2): 757-761.
Impact Factor: 2.989
View Export to BibTeX Export to EndNote
Verdoliva A, Marasco D, De Capua A, Saporito A, Bellofiore P, Manfredi V, Fattorusso R, Pedone C, Ruvo M
* A new ligand for immunoglobulin G subdomains by screening of a synthetic peptide library (482 views)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-7633electronic), 2005 Jul; 6(7): 1242-1253.
Impact Factor: 3.94
View Export to BibTeX Export to EndNote
Russo M, Palumbo R, Mupo A, Tosto M, Iacomino G, Scognamiglio A, Tedesco I, Galano G, Russo GL
* Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Cα (436 views)
Oncogene (ISSN: 0950-9232, 1476-5594), 2003; 22(21): 3330-3342.
Impact Factor: 6.495
View Export to BibTeX Export to EndNote
Fassina G, Ruvo M, Palombo G, Verdoliva A, Marino M
* Novel ligands for the affinity-chromatographic purification of antibodies (1283 views)
J Biochem Biophys Methods (ISSN: 0165-022x, 0165-022xlinking), 2001 Oct 30; 49(1-3): 481-490.
Impact Factor: 1.218
View Export to BibTeX Export to EndNote
Fonti R, Levchenko A, Mehta BM, Zhang J, Tsuruo T, Larson SM
Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography (312 views)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1999 Jan; 26(1): 35-41.
Impact Factor: 1.623
View Export to BibTeX Export to EndNote
Monti SM, Fogliano V, Randazzo G, Peluso G, Logrieco A, Ritieni A
Polyclonal antibodies against fusaproliferin (314 views)
Can J Microbiol (ISSN: 0008-4166), 1999 Jan; 45(1): 45-50.
Impact Factor: 1.072
View Export to BibTeX Export to EndNote
Fonti R, Cheung N-KV, Bridger GJ, Guo H-F, Abrams MJ, Larson SM
99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors (372 views)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1999; 26(6): 681-686.
Impact Factor: 1.623
View Export to BibTeX Export to EndNote
Renda A, Iovino F, Capasso L, Ricciardelli L, Tammaro V, Acampa W
Radioimmunoguided surgery in colorectal cancer: A 6-year experience with four different technical solutions (314 views)
Semin Surg Oncol Wiley Liss Inc (ISSN: 8756-0437), 1998 Dec; 15(4): 226-230.
Impact Factor: 1.045
View Export to BibTeX Export to EndNote
Pace L, Catalano L, Pinto A, De Renzo A, Di Gennaro F, Califano C, Del Vecchio S, Rotoli B, Salvatore M
Different patterns of technetium-99m sestamibi uptake in multiple myeloma (346 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1998 Jul; 25(7): 714-720.
Impact Factor: 2.564
View Export to BibTeX Export to EndNote
Levchenko A, Mehta B, Spengler BA, Narkar A, Fonti R, Biedler JL, Tsuruo T, Larson SM
Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay (283 views)
Anal Biochem (ISSN: 0003-2697, 1096-0309electronic, 0003-2697linking), 1996 May 1; 236(2): 338-343.
Impact Factor: 2.017
View Export to BibTeX Export to EndNote
Li PY, Del Vecchio S, Fonti R, Carriero MV, Potena MI, Botti G, Miotti S, Lastoria S, Menard S, Colnaghi MI, Salvatore M
Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography (450 views)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1996 Apr; 37(4-6): 665-672.
Impact Factor: 3.491
View Export to BibTeX Export to EndNote
Carriero MV, Franco P, Del Vecchio S, Massa O, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M
Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies (462 views)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1994 Oct 15; 54(20): 5445-5454.
Impact Factor: 8.426
View Export to BibTeX Export to EndNote
Caraglia M, Tagliaferri P, Correale P, Genua G, Pinto A, Del Vecchio S, Esposito G, Bianco AR
CYTOSINE-ARABINOSIDE INCREASES THE BINDING OF I-125 LABELED EPIDERMAL GROWTH-FACTOR AND I-125 TRANSFERRIN AND ENHANCES THE IN-VITRO TARGETING OF HUMAN TUMOR-CELLS WITH ANTI-(GROWTH FACTOR-RECEPTOR) MAB (327 views)
Cancer Immunol Immunother (ISSN: 0340-7004, 0340-7004linking), 1993 Sep; 37(3): 150-156.
Impact Factor: 1.269
View Export to BibTeX Export to EndNote
Caraglia M, Tagliaferri P, Correale P, Genua G, Pinto A, Del Vecchio S, Esposito G, Bianco AR
Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb (236 views)
Cancer Immunol Immunother (ISSN: 0340-7004linking), 1993 Aug; 37 (3 ): 150-156.
Impact Factor: 4.293
View Export to BibTeX Export to EndNote
D'Aiuto G, Del Vecchio S, Mansi L, D'Aprile M, Botti G, Salvatore M
Malignant melanoma of the nipple: A case studied with radiolabeled monoclonal antibody (619 views)
Tumori (ISSN: 0300-8916, 0300-8916print, 0300-8916linking), 1991 Oct 31; 77(5): 449-451.
Impact Factor: 0.408
View Export to BibTeX Export to EndNote
Manna R, Salvatore M, Di Leo MA, Scuderi F, Greco AV, Ghirlanda G, Gambassi G
Relationship between urinary neopterin excretion and islet cell antibodies in type 1 (insulin-dependent) diabetes (432 views)
Diabetes Res (ISSN: 0265-5985), 1991 May; 17(1): 33-36.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Camera L, Del Vecchio S, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M
Evaluation of therapeutic response using iodine-131-B72. 3 monoclonal antibody in patients with ovarian carcinoma (463 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991 Apr; 18(4): 269-273.
Impact Factor: 2.692
View Export to BibTeX Export to EndNote
Del Vecchio S, Camera L, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M
Clinical studies with B72. 3 in ovarian cancer and probe-guided tumor localization (405 views)
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1991; 18(1): 85-87.
Impact Factor: 1.042
View Export to BibTeX Export to EndNote
Del Vecchio S, Mansi L, Petrillo A, Camera L, Sofia M, Marra A, Carratú L, Salvatore M
Endobronchial administration of iodine-131 B72. 3 monoclonal antibody in patients with lung cancer (292 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991; 18(2): 129-132.
Impact Factor: 2.692
View Export to BibTeX Export to EndNote
Papa V, Reese CC, Brunetti A, Vigneri R, Siiteri PK, Goldfine ID
Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells (442 views)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1990 Dec 15; 50(24): 7858-7862.
Impact Factor: 8.426
View Export to BibTeX Export to EndNote
Valenza V, Maussier ML, D'Errico G, Lemmo GF, Frontera D, Ferrante A, Saletnich I, Valli A, Quarantelli M
Cancer of the pancreas and the periampullary region: The usefulness of tumor marker products with the monoclonal antibody technique (292 views)
J Nucl Med Allied Sci (ISSN: 0392-0208), 1990 Oct; 34(4SUPPL.): 131-134.
Impact Factor: 1.91
View Export to BibTeX Export to EndNote
Del Vecchio S, Reynolds JC
NONUNIFORM DISTRIBUTION OF RADIOLABELED MONOCLONAL-ANTIBODY IN TUMOR (270 views)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1990 Jul; 31(7): 1252-1252.
Impact Factor: 3.491
View Export to BibTeX Export to EndNote
Steis RG, Carrasquillo JA, Mccabe R, Bookman MA, Reynolds JC, Larson SM, Smith JW, Clark JW, Dailey V, Del Vecchio S
Toxicity, immunogenicity, and tumor radioimmunodetecting ability of two human monoclonal antibodies in patients with metastatic colorectal carcinoma (318 views)
J Clin Oncol (ISSN: 0732-183x, 0732-183xlinking), 1990 Mar; 8(3): 476-490.
Impact Factor: 7.878
View Export to BibTeX Export to EndNote
Trischitta V, Wong KY, Brunetti A, Scalisi R, Vigneri R, Goldfine ID
Endocytosis, recycling, and degradation of the insulin receptor. Studies with monoclonal antireceptor antibodies that do not activate receptor kinase (316 views)
Jbc Papers (ISSN: 0021-9258, 1083-351x, 0021-9258linking), 1989 Mar 25; 264(9): 5041-5046.
Impact Factor: 6.963
View Export to BibTeX Export to EndNote
d'Onofrio G, Menichella G, Zini G, Rumi C, Pierelli L, Quarantelli M, Puggioni PL, Mango G
Lymphocyte subset counting by immunoperoxidase using an automated routine hematologic analyzer (403 views)
Haematologica (ISSN: 0390-6078, 0006-4971, 0006-6497), 1989 Mar; 74(2): 137-142.
Impact Factor: 2.56
View Export to BibTeX Export to EndNote
Reynolds JC, Del Vecchio S, Sakahara H, Lora ME, Carrasquillo JA, Neumann RD, Larson SM
ANTI-MURINE ANTIBODY RESPONSE TO MOUSE MONOCLONAL ANTIBODIES CLINICAL FINDINGS AND IMPLICATIONS (660 views)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1989; 16(2): 121-125.
Impact Factor: 1.042
View Export to BibTeX Export to EndNote
Salvatore M, Lastoria S, Del Vecchio S, Mansi L
Detection of colon cancer with radiolabelled monoclonal antibodies (301 views)
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1989; 16(2): 103-104.
Impact Factor: 1.042
View Export to BibTeX Export to EndNote
Del Vecchio S, Reynolds JC, Carrasquillo JA, Blasberg RG, Neumann RD, Lotze MT, Bryant GJ, Farkas RJ, Larson SM
Local distribution and concentration of intravenously injected 131I-9. 2. 27 monoclonal antibody in human malignant melanoma (350 views)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1989; 49(10): 2783-2789.
Impact Factor: 8.426
View Export to BibTeX Export to EndNote
Manna R, Salvatore M, Scuderi F, Papa G, Marietti G, Greco AV, Ghirlanda G, Gambassi G
Negative correlation between ICA persistence and beta cell restoration after IDDM diagnosis (318 views)
Diabetes Res (ISSN: 0265-5985), 1988 Nov; 9(3): 101-103.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Del Vecchio S, Reynolds JC, Blasberg RG, Neumann RD, Carrasquillo JA, Hellström I, Larson SM
Measurement of local Mr 97, 000 and 250, 000 protein antigen concentration in sections of human melanoma tumor using in vitro quantitative autoradiography (528 views)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1988; 48(19): 5475-5481.
Impact Factor: 8.426
View Export to BibTeX Export to EndNote
* Post-translational modifications in tumor-associated carbonic anhydrases (22 views)
Amino Acids (ISSN: 0939-4451linking, 1438-2199electronic), 2022 Apr; 54(4): 543-558.
Impact Factor: 3.46
View Export to BibTeX Export to EndNote
Moreira M, Ruggiero A, Iaccarino E, Barra G, Sandomenico A, Ruvo M, Berisio R
* A structure-based approach for the development of a bicyclic peptide acting as a miniaturized anti-CD55 antibody (31 views) (PDF 16 views)
Int J Biol Macromol (ISSN: 0141-8130linking, 1879-0003electronic), 2021 May 17; 182: 1455-1462.
Impact Factor: 6.95
View Export to BibTeX Export to EndNote
Sivaccumar JP, Leonardi A, Iaccarino E, Corvino G, Sanguigno L, Chambery A, Russo R, Valletta M, Latino D, Capasso D, Doti N, Ruvo M, Sandomenico A
* Development of a New Highly Selective Monoclonal Antibody against Preferentially Expressed Antigen in Melanoma (PRAME) and Identification of the Target Epitope by Bio-Layer Interferometry (17 views)
Int J Mol Sc (ISSN: 1422-0067linking, 1422-0067electronic, 1661-6596), 2021 Mar 20; 22(6): N/D-N/D.
Impact Factor: 4.556
View Export to BibTeX Export to EndNote
Langella E, Buonanno M, De Simone G, Monti SM
* Intrinsically disordered features of carbonic anhydrase IX proteoglycan-like domain (30 views)
Cell Mol Life Sci (ISSN: 1420-682xlinking), 2021 Mar; 78(5): 2059-2067.
Impact Factor: 9.261
View Export to BibTeX Export to EndNote
Gogliettino M, Cocca E, Sandomenico A, Gratino L, Iaccarino E, Calvanese L, Rossi M, Palmieri G
* Selective inhibition of acylpeptide hydrolase in SAOS-2 osteosarcoma cells: is this enzyme a viable anticancer target? (20 views)
Mol Biol Rep (ISSN: 0301-4851linking), 2021 Feb; 48(2): 1505-1519.
Impact Factor: 2.316
View Export to BibTeX Export to EndNote
Sivaccumar J, Sandomenico A, Vitagliano L, Ruvo M
* Monoclonal Antibodies: A Prospective and Retrospective View (71 views)
Curr Med Chem (ISSN: 0929-8673linking, 1875-533xelectronic), 2021; 28(3): 435-471.
Impact Factor: 4.184
View Export to BibTeX Export to EndNote
Canassa-deleo T, Campo VL, Rodrigues LC, Marchiori MF, Fuzo C, Brigido MM, Sandomenico A, Ruvo M, Maranhao AQ, Dias-baruffi M
* Multifaceted antibodies development against synthetic alpha-dystroglycan mucin glycopeptide as promising tools for dystroglycanopathies diagnostic (157 views)
Glycoconj J (ISSN: 0282-0080linking), 2020 Feb; 37(1): 77-93.
Impact Factor: 2.197
View Export to BibTeX Export to EndNote
Langella E, Buonanno M, De Simone G, Monti SM
* Intrinsically disordered features of carbonic anhydrase IX proteoglycan-like domain (94 views)
Cell Mol Life Sci (ISSN: 1420-682xlinking), 2020; 21: 8405-8405.
Impact Factor: 6.496
View Export to BibTeX Export to EndNote
Di Stasi R, De Rosa L, Diana D, Fattorusso R, D'Andrea LD
* Human Recombinant VEGFR2D4 Biochemical Characterization to Investigate Novel Anti-VEGFR2D4 Antibodies for Allosteric Targeting of VEGFR2 (287 views)
Mol Biotechnol (ISSN: 1073-6085linking, 1559-0305electronic), 2019 Apr 26; 61(7): 513-520.
Impact Factor: 2.275
View Export to BibTeX Export to EndNote
Foca G, Iaccarino E, Foca A, Sanguigno L, Untiveros G, Cuevas-nunez M, Strizzi L, Leonardi A, Ruvo M, Sandomenico A
* Development of conformational antibodies targeting Cripto-1 with neutralizing effects in vitro (535 views)
Biochimie (ISSN: 0300-9084linking, 1638-6183electronic), 2019 Mar; 158: 246-256.
Impact Factor: 3.787
View Export to BibTeX Export to EndNote
De Simone G
* Targeted treatment of anaerobic cancer. Patent evaluation of US2016279084 and US2017056350 (225 views)
Expert Opin Ther Pat (ISSN: 1744-7674electronic, 1354-3776linking), 2019 Jan; 29(1): 1-6.
Impact Factor: 3.699
View Export to BibTeX Export to EndNote
Langella E, Buonanno M, Vullo D, Dathan N, Leone M, Supuran C, De Simone G, Monti SM
* Biochemical, biophysical and molecular dynamics studies on the proteoglycan-like domain of carbonic anhydrase IX (317 views)
Cell Mol Life Sci (ISSN: 1420-682xlinking), 2018 Sep; 75(17): 3283-3296.
Impact Factor: 6.721
View Export to BibTeX Export to EndNote
Mishra CB, Kumari S, Angeli A, Bua S, Buonanno M, Monti SM, Tiwari M, Supuran CT
* Discovery of potent anti-convulsant carbonic anhydrase inhibitors: Design, synthesis, in vitro and in vivo appraisal (234 views)
Eur J Med Chem (ISSN: 0223-5234linking, 1768-3254electronic), 2018 Aug 5; 156: 430-443.
Impact Factor: 4.816
View Export to BibTeX Export to EndNote
Calvanese L, Foca A, Sandomenico A, Foca G, Caporale A, Doti N, Iaccarino E, Leonardi A, D'Auria G, Ruvo M, Falcigno L
* Structural insights into the interaction of a monoclonal antibody and Nodal peptides by STD-NMR spectroscopy (499 views)
Bioorg Med Chem (ISSN: 0968-0896, 1464-3391, 0968-0896linking), 2017 Dec 15; 25(24): 6589-6596.
Impact Factor: 2.881
View Export to BibTeX Export to EndNote
Maglio O, Costanzo S, Cercola R, Zambrano G, Mauro M, Battaglia R, Ferrini G, Nastri F, Pavone V, Lombardi A
* A Quartz Crystal Microbalance Immunosensor for Stem Cell Selection and Extraction (507 views) (PDF 151 views)
Sensors (ISSN: 1424-8220, 1424-3210, 1424-8220linking), 2017 Nov 28; 17(12): N/D-N/D.
Impact Factor: 2.475
View Export to BibTeX Export to EndNote
Buonanno M, Langella E, Zambrano N, Succoio M, Sasso E, Alterio V, Di Fiore A, Sandomenico A, Supuran CT, Scaloni A, Monti SM, De Simone G
* Disclosing the Interaction of Carbonic Anhydrase IX with Cullin-Associated NEDD8-Dissociated Protein 1 by Molecular Modeling and Integrated Binding Measurements (279 views)
Acs Chem Biol (ISSN: 1554-8929), 2017 Apr 19; N/D: N/D-N/D.
Impact Factor: 4.592
View Export to BibTeX Export to EndNote
Leiria Campo V, Riul TB, Oliveira Bortot L, Martins-teixeira MB, Fiori Marchiori M, Iaccarino E, Ruvo M, Dias-baruffi M, Carvalho I
* A Synthetic MUC1 Glycopeptide Bearing betaGalNAc-Thr as a Tn Antigen Isomer Induces the Production of Antibodies against Tumor Cells (1299 views)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-4227linking), 2017 Mar 16; 18(6): 527-538.
Impact Factor: 2.774
View Export to BibTeX Export to EndNote
Sandomenico A, Focà A, Sanguigno L, Caporale A, Focà G, Pignalosa A, Corvino G, Caragnano A, Beltrami AP, Antoniali G, Tell G, Leonardi A, Ruvo M
* Monoclonal antibodies against pools of mono- and polyacetylated peptides selectively recognize acetylated lysines within the context of the original antigen (391 views) (PDF 219 views)
Mabs-Austin (ISSN: 1942-0862), 2016 Aug; 8: 1575-1589.
Impact Factor: 4.881
View Export to BibTeX Export to EndNote
Quero G, Consales M, Severino R, Vaiano P, Boniello A, Sandomenico A, Ruvo M, Borriello A, Diodato L, Zuppolini S, Giordano M, Nettore IC, Mazzarella C, Colao A, Macchia PE, Santorelli F, Cutolo A, Cusano A
* Long period fiber grating nano-optrode for cancer biomarker detection (309 views) (PDF 203 views)
Biosens Bioelectron (ISSN: 0956-5663, 1873-4235electronic), 2016 Feb 13; 80: 590-600.
Impact Factor: 7.78
View Export to BibTeX Export to EndNote
Sandomenico A, Leonardi A, Berisio R, Sanguigno L, Foca G, Foca A, Ruggiero A, Doti N, Muscariello L, Barone D, Farina C, Owsianka A, Vitagliano L, Patel AH, Ruvo M
* Generation and characterization of monoclonal antibodies against a cyclic variant of Hepatitis C Virus E2 epitope 412-422 (445 views) (PDF 201 views)
J Virol (ISSN: 0022-538x, 0022-538xlinking), 2016 Jan 27; 90(7): 3745-3759.
Impact Factor: 4.663
View Export to BibTeX Export to EndNote
Bogdanovich S, Kim Y, Mizutani T, Yasuma R, Tudisco L, Cicatiello V, Bastos-carvalho A, Kerur N, Hirano Y, Baffi JZ, Tarallo V, Li S, Yasuma T, Arpitha P, Fowler BJ, Wright CB, Apicella I, Greco A, Brunetti A, Ruvo M, Sandomenico A, Nozaki M, Ijima R, Kaneko H, Ogura Y, Terasaki H, Ambati BK, Leusen JH, Langdon WY, Clark MR, Armour KL, Bruhns P, Verbeek JS, Gelfand BD, De Falco S, Ambati J
* Human IgG1 antibodies suppress angiogenesis in a target-independent manner (557 views)
Signal Transduct Target Ther (ISSN: 2059-3635print), 2016; 1: N/D-N/D.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Palladino P, Aura AM, Spoto G
* Surface plasmon resonance for the label-free detection of Alzheimer's β-amyloid peptide aggregation (528 views)
Anal Bioanal Chem (ISSN: 1618-2642), 2016; 408(3): 849-854.
Impact Factor: 3.431
View Export to BibTeX Export to EndNote
Foca A, Sanguigno L, Foca G, Strizzi L, Iannitti R, Palumbo R, Hendrix MJ, Leonardi A, Ruvo M, Sandomenico A
* New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding (718 views) (PDF 265 views)
Int J Mol Sc (ISSN: 1422-0067, 1661-6596, 1422-0067linking), 2015 Sep 7; 16(9): 21342-21362.
Impact Factor: 3.257
View Export to BibTeX Export to EndNote
Klauzinska M, Bertolette D, Tippireddy S, Strizzi L, Gray PC, Gonzales M, Duroux M, Ruvo M, Wechselberger C, Castro NP, Rangel MC, Focà A, Sandomenico A, Hendrix MJC, Salomon D, Cuttitta F
* Cripto-1: an extracellular protein – connecting the sequestered biological dots (296 views)
Connect Tissue Res (ISSN: 0300-8207), 2015; N/D: N/D-N/D.
Impact Factor: 1.411
View Export to BibTeX Export to EndNote
Lanzillo R, Liuzzi R, Vallefuoco L, Moccia M, Amato L, Vacca G, Vacchiano V, Portella G, Brescia Morra V
* JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level (324 views)
Ther Clin Risk Manag (ISSN: 1178-203x), 2014 Oct 9; 10: 807-814.
Impact Factor: 1.469
View Export to BibTeX Export to EndNote
Gallicchio R, Mansueto G, Simeon V, Nardelli A, Guariglia R, Capacchione D, Soscia E, Pedicini P, Gattozzi D, Musto P, Storto G
* F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma (531 views)
Eur J Haematol (ISSN: 0902-4441), 2014 May; 92(5): 382-389.
Impact Factor: 2.066
View Export to BibTeX Export to EndNote
Rami M, Dubois L, Parvathaneni NK, Alterio V, van Kuijk SJ, Monti SM, Lambin P, De Simone G, Supuran CT, Winum JY
* Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates (546 views)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2013 Nov 14; 56(21): 8512-8520.
Impact Factor: 5.48
View Export to BibTeX Export to EndNote
Lanzillo R, Bonavita S, Quarantelli M, Vacca G, Lus G, Amato L, Carotenuto A, Tedeschi G, Orefice G, Brescia Morra V
* Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice (312 views)
Neurol Sci (ISSN: 1590-1874, 1590-0187, 1590-3478), 2013 Apr; 34(4): 521-528.
Impact Factor: 0.38
View Export to BibTeX Export to EndNote
Calce E, Monfregola L, Sandomenico A, Saviano M, De Luca S
* Fluorescence study for selecting specific ligands toward HER2 receptor: An example of receptor fragment approach (438 views)
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 1768-3254electronic), 2013 Mar; 61: 116-121.
Impact Factor: 3.432
View Export to BibTeX Export to EndNote
Rosa R, Marciano R, Malapelle U, Formisano L, Nappi L, D'Amato C, D'Amato V, Damiano V, Marf G, Del Vecchio S, Zannetti A, Greco A, De Stefano A, Carlomagno C, Veneziani BM, Troncone G, De Placido S, Bianco R
* Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models (672 views)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2013 Jan 1; 19(1): 138-147.
Impact Factor: 8.193
View Export to BibTeX Export to EndNote
Buanne P, Renzone G, Monteleone F, Vitale M, Monti SM, Sandomenico A, Garbi C, Montanaro D, Accardo M, Troncone G, Zatovicova M, Csaderova L, Supuran CT, Pastorekova S, Scaloni A, De Simone G, Zambrano N
* Characterization of carbonic anhydrase ix interactome reveals proteins assisting its nuclear localization in hypoxic cells (393 views)
J Proteome Res (ISSN: 1535-3893), 2013 Jan; 12(1): 282-292.
Impact Factor: 5.001
View Export to BibTeX Export to EndNote
Lanzillo R, Quarantelli M, Bonavita S, Ventrella G, Lus G, Vacca G, Prinster A, Orefice G, Tedeschi G, Brescia Morra V
* Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: A head-to-head retrospective study (400 views)
Acta Neurol Scand (ISSN: 0001-6314, 1600-0404), 2012 Nov; 126(5): 306-314.
Impact Factor: 2.474
View Export to BibTeX Export to EndNote
Tagliamonte M, Marasco D, Ruggiero A, de Stradis A, Tornesello ML, Totrov M, Buonaguro FM, Buonaguro L
* HIV p24 as Scaffold for Presenting Conformational HIV Env Antigens (405 views)
Plosone (ISSN: 1932-6203, 1932-6203electronic, 1932-6203linking), 2012 Sep 17; 7(8): N/D-N/D.
Impact Factor: 3.73
View Export to BibTeX Export to EndNote
Risitano AM, Imbriaco M, Marando L, Seneca E, Soscia E, Malcovati L, Iori AP, Pane F, Notaro R, Matarazzo M
* From perpetual haemosiderinuria to possible iron overload: iron redistribution in paroxysmal nocturnal haemoglobinuria patients on eculizumab by magnetic resonance imaging (359 views)
Br J Haematol (ISSN: 0007-1048, 0007-1048linking, 1365-2141electronic), 2012 Sep; 158(3): 415-418.
Impact Factor: 4.942
View Export to BibTeX Export to EndNote
Pedicini P, Caivano R, Jereczek-Fossa BA, Strigari L, Vischioni B, Alterio D, Cremonesi M, Botta F, Nappi A, Improta G, Storto G, Benassi M, Orecchia R
* Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors (382 views)
Theor Biol Med Model (ISSN: 1742-4682), 2012 Jun 19; 9(1): 23-23.
Impact Factor: 1.461
View Export to BibTeX Export to EndNote
Monti SM, Supuran CT, De Simone G
* Carbonic anhydrase IX as a target for designing novel anticancer drugs (526 views)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2012 Feb; 19(6): 821-830.
Impact Factor: 4.07
View Export to BibTeX Export to EndNote
Troise F, Monti M, Merlino A, Cozzolino F, Fedele C, Russo Krauss I, Sica F, Pucci P, D'Alessio G, De Lorenzo C
* A novel ErbB2 epitope targeted by human antitumor immunoagents (391 views)
Febs Journal (ISSN: 1742-464x), 2011 Apr; 278(7): 1156-1166.
Impact Factor: 3.79
View Export to BibTeX Export to EndNote
Lanzillo R, Orefice G, Prinster A, Ventrella G, Liuzzi R, Scarano V, Florio C, Vacca G, Brunetti A, Alfano B, Brescia Morra V, Bonavita V
* Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapy (314 views) (PDF 221 views)
Neurol Sci (ISSN: 1590-1874, 1590-3478, 1590-1874linking), 2011 Apr; 32(2): 287-292.
Impact Factor: 1.315
View Export to BibTeX Export to EndNote
Palmieri C, Falcone C, Iaccino E, Tuccillo FM, Gaspari M, Trimboli F, De Laurentiis A, Luberto L, Pontoriero M, Pisano A, Vecchio E, Fierro O, Panico M, Larobina M, Gargiulo S, Costa N, Dal Piaz F, Schiavone M, Arra C, Giudice A, Palma G, Barbieri A, Quinto I, Scala G
* In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder (581 views)
Blood (ISSN: 0006-4971, 0006-6497, 0390-6078), 2010 Jul 15; 116(2): 226-238.
Impact Factor: 10.558
View Export to BibTeX Export to EndNote
Alberobello AT, D'Esposito V, Marasco D, Doti N, Ruvo M, Bianco R, Tortora G, Esposito I, Fiory F, Miele C, Beguinot F, Formisano P
* Selective Disruption of Insulin-like Growth Factor-1 (IGF-1) Signaling via Phosphoinositide-dependent Kinase-1 Prevents the Protective Effect of IGF-1 on Human Cancer Cell Death (578 views)
Jbc Papers (ISSN: 0021-9258, 1083-351x, 0021-9258linking), 2010 Feb 26; 285(9): 6563-6572.
Impact Factor: 5.328
View Export to BibTeX Export to EndNote
De Simone G, Supuran CT
* Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target (398 views)
Bba-Gen Subjects (ISSN: 1570-9639, 0006-3002, 0925-4439), 2010 Feb; 1804(2): 404-409.
Impact Factor: 2.773
View Export to BibTeX Export to EndNote
Storto G, De Renzo A, Pellegrino T, Perna F, De Falco T, Erra P, Nardelli A, Speranza A, Klain M, Rotoli B, Pace L
* Assessment of Metabolic Response to Radioimmunotherapy with (90)Y-Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (399 views)
Radiology (ISSN: 0033-8419, 1527-1315, 0033-8419linking), 2010 Jan; 254(1): 245-252.
Impact Factor: 6.069
View Export to BibTeX Export to EndNote
Guler OO, De Simone G, Supuran CT
* Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII (540 views)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2010; 17(15): 1516-1526.
Impact Factor: 4.63
View Export to BibTeX Export to EndNote
Supuran CT, Di Fiore A, Alterio V, Monti SM, De Simone G
* Recent advances in structural studies of the carbonic anhydrase family: The crystal structure of human CA IX and CA XIII (471 views)
Curr Pharm Des Current Pharmaceutical Design (ISSN: 1381-6128, 1873-4286), 2010; 16(29): 3246-3254.
Impact Factor: 4.774
View Export to BibTeX Export to EndNote
Giurato P, Candura A, Grasso G, Spoto G
* In situ identification of organic components of ink used in books from the 1900s by atmospheric pressure matrix assisted laser desorption ionization mass spectrometry (303 views)
Appl Phys A (ISSN: 0947-8396), 2009 Nov; 97(2): 263-269.
Impact Factor: 1.595
View Export to BibTeX Export to EndNote
Alterio V, Hilvo M, Di Fiore A, Supuran CT, Pan P, Parkkila S, Scaloni A, Pastorek J, Pastorekova S, Pedone C, Scozzafava A, Monti SM, De Simone G
* Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX (571 views)
P Natl Acad Sci Usa (ISSN: 0027-8424, 1091-6490, 0027-8424print), 2009 Sep 22; 106(38): 16233-16238.
Impact Factor: 9.432
View Export to BibTeX Export to EndNote
Ragno R, Simeoni S, Castellano S, Vicidomini C, Mai A, Caroli A, Tramontano A, Bonaccini C, Trojer P, Bauer I, Brosch G, Sbardella G
* Small molecule inhibitors of histone arginine methyltransferases: Homology modeling, molecular docking, binding mode analysis, and biological evaluations (781 views)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2007 Mar 22; 50(6): 1241-1253.
Impact Factor: 4.895
View Export to BibTeX Export to EndNote
Palmieri G, Marino M, Salvatore M, Budillon A, Meo G, Caraglia M, Montella L
* Cetuximab is an active treatment of metastatic and chemorefractory thymoma (372 views)
Frontiers In Bioscience (ISSN: 1093-9946, 1093-4715), 2007 Jan 1; 12(2): 757-761.
Impact Factor: 2.989
View Export to BibTeX Export to EndNote
Verdoliva A, Marasco D, De Capua A, Saporito A, Bellofiore P, Manfredi V, Fattorusso R, Pedone C, Ruvo M
* A new ligand for immunoglobulin G subdomains by screening of a synthetic peptide library (482 views)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-7633electronic), 2005 Jul; 6(7): 1242-1253.
Impact Factor: 3.94
View Export to BibTeX Export to EndNote
Russo M, Palumbo R, Mupo A, Tosto M, Iacomino G, Scognamiglio A, Tedesco I, Galano G, Russo GL
* Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Cα (436 views)
Oncogene (ISSN: 0950-9232, 1476-5594), 2003; 22(21): 3330-3342.
Impact Factor: 6.495
View Export to BibTeX Export to EndNote
Fassina G, Ruvo M, Palombo G, Verdoliva A, Marino M
* Novel ligands for the affinity-chromatographic purification of antibodies (1283 views)
J Biochem Biophys Methods (ISSN: 0165-022x, 0165-022xlinking), 2001 Oct 30; 49(1-3): 481-490.
Impact Factor: 1.218
View Export to BibTeX Export to EndNote
Fonti R, Levchenko A, Mehta BM, Zhang J, Tsuruo T, Larson SM
Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography (312 views)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1999 Jan; 26(1): 35-41.
Impact Factor: 1.623
View Export to BibTeX Export to EndNote
Monti SM, Fogliano V, Randazzo G, Peluso G, Logrieco A, Ritieni A
Polyclonal antibodies against fusaproliferin (314 views)
Can J Microbiol (ISSN: 0008-4166), 1999 Jan; 45(1): 45-50.
Impact Factor: 1.072
View Export to BibTeX Export to EndNote
Fonti R, Cheung N-KV, Bridger GJ, Guo H-F, Abrams MJ, Larson SM
99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors (372 views)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1999; 26(6): 681-686.
Impact Factor: 1.623
View Export to BibTeX Export to EndNote
Renda A, Iovino F, Capasso L, Ricciardelli L, Tammaro V, Acampa W
Radioimmunoguided surgery in colorectal cancer: A 6-year experience with four different technical solutions (314 views)
Semin Surg Oncol Wiley Liss Inc (ISSN: 8756-0437), 1998 Dec; 15(4): 226-230.
Impact Factor: 1.045
View Export to BibTeX Export to EndNote
Pace L, Catalano L, Pinto A, De Renzo A, Di Gennaro F, Califano C, Del Vecchio S, Rotoli B, Salvatore M
Different patterns of technetium-99m sestamibi uptake in multiple myeloma (346 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1998 Jul; 25(7): 714-720.
Impact Factor: 2.564
View Export to BibTeX Export to EndNote
Levchenko A, Mehta B, Spengler BA, Narkar A, Fonti R, Biedler JL, Tsuruo T, Larson SM
Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay (283 views)
Anal Biochem (ISSN: 0003-2697, 1096-0309electronic, 0003-2697linking), 1996 May 1; 236(2): 338-343.
Impact Factor: 2.017
View Export to BibTeX Export to EndNote
Li PY, Del Vecchio S, Fonti R, Carriero MV, Potena MI, Botti G, Miotti S, Lastoria S, Menard S, Colnaghi MI, Salvatore M
Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography (450 views)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1996 Apr; 37(4-6): 665-672.
Impact Factor: 3.491
View Export to BibTeX Export to EndNote
Carriero MV, Franco P, Del Vecchio S, Massa O, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M
Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies (462 views)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1994 Oct 15; 54(20): 5445-5454.
Impact Factor: 8.426
View Export to BibTeX Export to EndNote
Caraglia M, Tagliaferri P, Correale P, Genua G, Pinto A, Del Vecchio S, Esposito G, Bianco AR
CYTOSINE-ARABINOSIDE INCREASES THE BINDING OF I-125 LABELED EPIDERMAL GROWTH-FACTOR AND I-125 TRANSFERRIN AND ENHANCES THE IN-VITRO TARGETING OF HUMAN TUMOR-CELLS WITH ANTI-(GROWTH FACTOR-RECEPTOR) MAB (327 views)
Cancer Immunol Immunother (ISSN: 0340-7004, 0340-7004linking), 1993 Sep; 37(3): 150-156.
Impact Factor: 1.269
View Export to BibTeX Export to EndNote
Caraglia M, Tagliaferri P, Correale P, Genua G, Pinto A, Del Vecchio S, Esposito G, Bianco AR
Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb (236 views)
Cancer Immunol Immunother (ISSN: 0340-7004linking), 1993 Aug; 37 (3 ): 150-156.
Impact Factor: 4.293
View Export to BibTeX Export to EndNote
D'Aiuto G, Del Vecchio S, Mansi L, D'Aprile M, Botti G, Salvatore M
Malignant melanoma of the nipple: A case studied with radiolabeled monoclonal antibody (619 views)
Tumori (ISSN: 0300-8916, 0300-8916print, 0300-8916linking), 1991 Oct 31; 77(5): 449-451.
Impact Factor: 0.408
View Export to BibTeX Export to EndNote
Manna R, Salvatore M, Di Leo MA, Scuderi F, Greco AV, Ghirlanda G, Gambassi G
Relationship between urinary neopterin excretion and islet cell antibodies in type 1 (insulin-dependent) diabetes (432 views)
Diabetes Res (ISSN: 0265-5985), 1991 May; 17(1): 33-36.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Camera L, Del Vecchio S, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M
Evaluation of therapeutic response using iodine-131-B72. 3 monoclonal antibody in patients with ovarian carcinoma (463 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991 Apr; 18(4): 269-273.
Impact Factor: 2.692
View Export to BibTeX Export to EndNote
Del Vecchio S, Camera L, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M
Clinical studies with B72. 3 in ovarian cancer and probe-guided tumor localization (405 views)
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1991; 18(1): 85-87.
Impact Factor: 1.042
View Export to BibTeX Export to EndNote
Del Vecchio S, Mansi L, Petrillo A, Camera L, Sofia M, Marra A, Carratú L, Salvatore M
Endobronchial administration of iodine-131 B72. 3 monoclonal antibody in patients with lung cancer (292 views)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991; 18(2): 129-132.
Impact Factor: 2.692
View Export to BibTeX Export to EndNote
Papa V, Reese CC, Brunetti A, Vigneri R, Siiteri PK, Goldfine ID
Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells (442 views)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1990 Dec 15; 50(24): 7858-7862.
Impact Factor: 8.426
View Export to BibTeX Export to EndNote
Valenza V, Maussier ML, D'Errico G, Lemmo GF, Frontera D, Ferrante A, Saletnich I, Valli A, Quarantelli M
Cancer of the pancreas and the periampullary region: The usefulness of tumor marker products with the monoclonal antibody technique (292 views)
J Nucl Med Allied Sci (ISSN: 0392-0208), 1990 Oct; 34(4SUPPL.): 131-134.
Impact Factor: 1.91
View Export to BibTeX Export to EndNote
Del Vecchio S, Reynolds JC
NONUNIFORM DISTRIBUTION OF RADIOLABELED MONOCLONAL-ANTIBODY IN TUMOR (270 views)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1990 Jul; 31(7): 1252-1252.
Impact Factor: 3.491
View Export to BibTeX Export to EndNote
Steis RG, Carrasquillo JA, Mccabe R, Bookman MA, Reynolds JC, Larson SM, Smith JW, Clark JW, Dailey V, Del Vecchio S
Toxicity, immunogenicity, and tumor radioimmunodetecting ability of two human monoclonal antibodies in patients with metastatic colorectal carcinoma (318 views)
J Clin Oncol (ISSN: 0732-183x, 0732-183xlinking), 1990 Mar; 8(3): 476-490.
Impact Factor: 7.878
View Export to BibTeX Export to EndNote
Trischitta V, Wong KY, Brunetti A, Scalisi R, Vigneri R, Goldfine ID
Endocytosis, recycling, and degradation of the insulin receptor. Studies with monoclonal antireceptor antibodies that do not activate receptor kinase (316 views)
Jbc Papers (ISSN: 0021-9258, 1083-351x, 0021-9258linking), 1989 Mar 25; 264(9): 5041-5046.
Impact Factor: 6.963
View Export to BibTeX Export to EndNote
d'Onofrio G, Menichella G, Zini G, Rumi C, Pierelli L, Quarantelli M, Puggioni PL, Mango G
Lymphocyte subset counting by immunoperoxidase using an automated routine hematologic analyzer (403 views)
Haematologica (ISSN: 0390-6078, 0006-4971, 0006-6497), 1989 Mar; 74(2): 137-142.
Impact Factor: 2.56
View Export to BibTeX Export to EndNote
Reynolds JC, Del Vecchio S, Sakahara H, Lora ME, Carrasquillo JA, Neumann RD, Larson SM
ANTI-MURINE ANTIBODY RESPONSE TO MOUSE MONOCLONAL ANTIBODIES CLINICAL FINDINGS AND IMPLICATIONS (660 views)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1989; 16(2): 121-125.
Impact Factor: 1.042
View Export to BibTeX Export to EndNote
Salvatore M, Lastoria S, Del Vecchio S, Mansi L
Detection of colon cancer with radiolabelled monoclonal antibodies (301 views)
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1989; 16(2): 103-104.
Impact Factor: 1.042
View Export to BibTeX Export to EndNote
Del Vecchio S, Reynolds JC, Carrasquillo JA, Blasberg RG, Neumann RD, Lotze MT, Bryant GJ, Farkas RJ, Larson SM
Local distribution and concentration of intravenously injected 131I-9. 2. 27 monoclonal antibody in human malignant melanoma (350 views)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1989; 49(10): 2783-2789.
Impact Factor: 8.426
View Export to BibTeX Export to EndNote
Manna R, Salvatore M, Scuderi F, Papa G, Marietti G, Greco AV, Ghirlanda G, Gambassi G
Negative correlation between ICA persistence and beta cell restoration after IDDM diagnosis (318 views)
Diabetes Res (ISSN: 0265-5985), 1988 Nov; 9(3): 101-103.
Impact Factor: 0
View Export to BibTeX Export to EndNote
Del Vecchio S, Reynolds JC, Blasberg RG, Neumann RD, Carrasquillo JA, Hellström I, Larson SM
Measurement of local Mr 97, 000 and 250, 000 protein antigen concentration in sections of human melanoma tumor using in vitro quantitative autoradiography (528 views)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1988; 48(19): 5475-5481.
Impact Factor: 8.426
View Export to BibTeX Export to EndNote
77 Records (74 excluding Abstracts).
Total impact factor: 295.783 (287.101 excluding Abstracts).
Total 5 year impact factor: 313.774 (302.478 excluding Abstracts).
Total impact factor: 295.783 (287.101 excluding Abstracts).
Total 5 year impact factor: 313.774 (302.478 excluding Abstracts).
532 views. Last view on Wednesday 22 March 2023, 7:38:42
ibb.cnr.it
